[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fGHNvbJQHcbrW9cRoDTP0lFf5DC_aHDd6-Nx0eJkc1vY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":37,"phaseBuckets":88,"rows":95},"Hospital de Clinicas de Porto Alegre",[4],442,false,44,50,215981,28,318,[14,17,20,23,25,28,31,34],{"name":15,"count":16},"Hypertension",24,{"name":18,"count":19},"Fibromyalgia",13,{"name":21,"count":22},"Heart Failure",12,{"name":24,"count":22},"Obesity",{"name":26,"count":27},"Diabetes Mellitus, Type 2",11,{"name":29,"count":30},"Pain",9,{"name":32,"count":33},"Chronic Pain",7,{"name":35,"count":36},"Attention Deficit Hyperactivity Disorder",6,[38,43,48,53,58,63,68,73,78,83],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT04018729","Cell Therapy Associated With Endobronchial Valve","2020-08-17","Marrow-derived mesenchymal stromal cell",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT04874012","Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes","2025-10","Active comparator Taurine",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT05454332","The Caffeine Therapy in the Fetal to Neonatal Transition","2025-12-31","Early Caffeine administration",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT06434025","IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency","2026-05-24","Iron Carboxymaltose",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT06622187","Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies","2026-06","Desmopressin",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT07489547","Medication Withdrawal in Stable HF With Improved LVEF","2026-12","Discontinuation of MRAs",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT06354439","Use of Letrozole for Ectopic Pregnancy","2026-12-31","Letrozole",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT06783478","NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial","2027-08-31","NK cell",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT06591884","Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus","2027-12","Tacrolimus modified-release",{"nctId":84,"briefTitle":85,"date":86,"intervention":87},"NCT06527560","Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis","2027-12-31","Cefuroxime",[89,90,91,92,93,94],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[96,122,147,169,187,209,227,253,271,292,310,346,364,382,400,418,440,465,489,507,538,559,580,602,620,645,663,692,710,741,779,807,825,849,875,893,922,940,958,976,1001,1026,1052,1070,1094,1119,1147,1165,1191,1216,1242,1266,1291,1317,1343,1361,1379,1397,1421,1439,1464,1482,1506,1529,1554,1600,1638,1675,1704,1730,1755,1779,1797,1824,1842,1866,1893,1911,1933,1960,1978,1996,2014,2038,2062,2080,2105,2123,2145,2170,2195,2220,2245,2272,2298,2323,2350,2376,2399,2417,2443,2465,2483,2509,2527,2545,2573,2595,2617,2642,2667,2690,2715,2733,2758,2780,2807,2825,2848,2875,2893,2919,2944,2969,2987,3012,3043,3061,3079,3097,3115,3133,3159,3183,3208,3230,3277,3317,3344,3366,3393,3426,3475,3497,3515,3541,3567,3585,3608,3632,3657,3683,3701,3725,3749,3772,3793,3811,3829,3847,3865,3883,3901,3919,3937,3955,3973,3991,4009,4027,4045,4063,4081,4099,4123,4149,4175,4193,4216,4241,4259,4277,4303,4321,4339,4357,4375,4393],{"intervention":52,"totalTrials":97,"cells":98},1,{"EARLY_PHASE1":99,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":120},{"trials":100,"activeCount":101},[],0,{"trials":103,"activeCount":101},[],{"trials":105,"activeCount":101},[],{"trials":107,"activeCount":101},[],{"trials":109,"activeCount":97,"soonestReadout":51},[110],{"nctId":49,"briefTitle":50,"status":111,"phases":112,"primaryCompletion":51,"completion":113,"start":114,"enrollment":9,"conditions":115,"interventions":119},"RECRUITING",[93],"2026-08-30","2022-04-27",[116,117,118],"Mechanical Ventilation Complication","Caffeine","Ventilator Lung; Newborn",[52],{"trials":121,"activeCount":101},[],{"intervention":123,"totalTrials":97,"cells":124},"Immediate-release Methylphenidate",{"EARLY_PHASE1":125,"PHASE1":127,"PHASE2":129,"PHASE3":131,"PHASE4":133,"NA":145},{"trials":126,"activeCount":101},[],{"trials":128,"activeCount":101},[],{"trials":130,"activeCount":101},[],{"trials":132,"activeCount":101},[],{"trials":134,"activeCount":97,"soonestReadout":139},[135],{"nctId":136,"briefTitle":137,"status":111,"phases":138,"primaryCompletion":139,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":144},"NCT02951754","Methylphenidate in Adults With Attention Deficit\u002FHyperactivity Disorder",[93],"2032-12","2002-02",600,[143],"Attention Deficit Disorder With Hyperactivity",[123],{"trials":146,"activeCount":101},[],{"intervention":72,"totalTrials":97,"cells":148},{"EARLY_PHASE1":149,"PHASE1":151,"PHASE2":153,"PHASE3":155,"PHASE4":157,"NA":167},{"trials":150,"activeCount":101},[],{"trials":152,"activeCount":101},[],{"trials":154,"activeCount":101},[],{"trials":156,"activeCount":101},[],{"trials":158,"activeCount":97,"soonestReadout":71},[159],{"nctId":69,"briefTitle":70,"status":111,"phases":160,"primaryCompletion":71,"completion":71,"start":161,"enrollment":162,"conditions":163,"interventions":165},[93],"2024-03-27",130,[164],"Ectopic Pregnancy",[72,166],"Methotrexate Sodium",{"trials":168,"activeCount":101},[],{"intervention":166,"totalTrials":97,"cells":170},{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":177,"PHASE4":179,"NA":185},{"trials":172,"activeCount":101},[],{"trials":174,"activeCount":101},[],{"trials":176,"activeCount":101},[],{"trials":178,"activeCount":101},[],{"trials":180,"activeCount":97,"soonestReadout":71},[181],{"nctId":69,"briefTitle":70,"status":111,"phases":182,"primaryCompletion":71,"completion":71,"start":161,"enrollment":162,"conditions":183,"interventions":184},[93],[164],[72,166],{"trials":186,"activeCount":101},[],{"intervention":87,"totalTrials":97,"cells":188},{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":195,"PHASE4":197,"NA":207},{"trials":190,"activeCount":101},[],{"trials":192,"activeCount":101},[],{"trials":194,"activeCount":101},[],{"trials":196,"activeCount":101},[],{"trials":198,"activeCount":97,"soonestReadout":86},[199],{"nctId":84,"briefTitle":85,"status":111,"phases":200,"primaryCompletion":86,"completion":86,"start":201,"enrollment":202,"conditions":203,"interventions":205},[93],"2024-09-09",100,[204],"Pyelonephritis in Pregnancy",[87,206],"Cefuroxime Axetil",{"trials":208,"activeCount":101},[],{"intervention":206,"totalTrials":97,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":225},{"trials":212,"activeCount":101},[],{"trials":214,"activeCount":101},[],{"trials":216,"activeCount":101},[],{"trials":218,"activeCount":101},[],{"trials":220,"activeCount":97,"soonestReadout":86},[221],{"nctId":84,"briefTitle":85,"status":111,"phases":222,"primaryCompletion":86,"completion":86,"start":201,"enrollment":202,"conditions":223,"interventions":224},[93],[204],[87,206],{"trials":226,"activeCount":101},[],{"intervention":62,"totalTrials":97,"cells":228},{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":251},{"trials":230,"activeCount":101},[],{"trials":232,"activeCount":101},[],{"trials":234,"activeCount":101},[],{"trials":236,"activeCount":101},[],{"trials":238,"activeCount":97,"soonestReadout":61},[239],{"nctId":59,"briefTitle":60,"status":240,"phases":241,"primaryCompletion":61,"completion":242,"start":243,"enrollment":244,"conditions":245,"interventions":249},"ENROLLING_BY_INVITATION",[93],"2026-06-14","2024-08-14",96,[246,247,62,248],"Bleeding","Transplant, Kidney","Kidney Biopsy",[62,250],"Sodium Chloride",{"trials":252,"activeCount":101},[],{"intervention":250,"totalTrials":97,"cells":254},{"EARLY_PHASE1":255,"PHASE1":257,"PHASE2":259,"PHASE3":261,"PHASE4":263,"NA":269},{"trials":256,"activeCount":101},[],{"trials":258,"activeCount":101},[],{"trials":260,"activeCount":101},[],{"trials":262,"activeCount":101},[],{"trials":264,"activeCount":97,"soonestReadout":61},[265],{"nctId":59,"briefTitle":60,"status":240,"phases":266,"primaryCompletion":61,"completion":242,"start":243,"enrollment":244,"conditions":267,"interventions":268},[93],[246,247,62,248],[62,250],{"trials":270,"activeCount":101},[],{"intervention":67,"totalTrials":97,"cells":272},{"EARLY_PHASE1":273,"PHASE1":275,"PHASE2":277,"PHASE3":279,"PHASE4":288,"NA":290},{"trials":274,"activeCount":101},[],{"trials":276,"activeCount":101},[],{"trials":278,"activeCount":101},[],{"trials":280,"activeCount":97,"soonestReadout":66},[281],{"nctId":64,"briefTitle":65,"status":111,"phases":282,"primaryCompletion":66,"completion":71,"start":283,"enrollment":284,"conditions":285,"interventions":286},[91,92],"2025-03-01",90,[21],[67,287],"Continue MRAs",{"trials":289,"activeCount":101},[],{"trials":291,"activeCount":101},[],{"intervention":287,"totalTrials":97,"cells":293},{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":300,"PHASE4":306,"NA":308},{"trials":295,"activeCount":101},[],{"trials":297,"activeCount":101},[],{"trials":299,"activeCount":101},[],{"trials":301,"activeCount":97,"soonestReadout":66},[302],{"nctId":64,"briefTitle":65,"status":111,"phases":303,"primaryCompletion":66,"completion":71,"start":283,"enrollment":284,"conditions":304,"interventions":305},[91,92],[21],[67,287],{"trials":307,"activeCount":101},[],{"trials":309,"activeCount":101},[],{"intervention":311,"totalTrials":97,"cells":312},"Furosemide 40 Milligrams.",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":342,"NA":344},{"trials":314,"activeCount":101},[],{"trials":316,"activeCount":101},[],{"trials":318,"activeCount":101},[],{"trials":320,"activeCount":97,"soonestReadout":326},[321],{"nctId":322,"briefTitle":323,"status":324,"phases":325,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":330,"interventions":337},"NCT07469722","POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","NOT_YET_RECRUITING",[91,92],"2028-01-31","2028-07-01","2026-03-23",128,[331,332,333,334,335,336],"Acute Heart Failure (AHF)","Congestive Heart Failure Acute","Diuretic Effect","Lung Ultrasonography Score","Ultrasonography, Doppler","Point-of-care Ultrasound (POCUS)",[311,311,338,339,340,341],"Hydrochlorothiazide (HCTZ) 25 milligrams.","Acetazolamide 250 milligrams.","Dapagliflozin","Potassium Chloride Oral Product",{"trials":343,"activeCount":101},[],{"trials":345,"activeCount":101},[],{"intervention":338,"totalTrials":97,"cells":347},{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":360,"NA":362},{"trials":349,"activeCount":101},[],{"trials":351,"activeCount":101},[],{"trials":353,"activeCount":101},[],{"trials":355,"activeCount":97,"soonestReadout":326},[356],{"nctId":322,"briefTitle":323,"status":324,"phases":357,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":358,"interventions":359},[91,92],[331,332,333,334,335,336],[311,311,338,339,340,341],{"trials":361,"activeCount":101},[],{"trials":363,"activeCount":101},[],{"intervention":339,"totalTrials":97,"cells":365},{"EARLY_PHASE1":366,"PHASE1":368,"PHASE2":370,"PHASE3":372,"PHASE4":378,"NA":380},{"trials":367,"activeCount":101},[],{"trials":369,"activeCount":101},[],{"trials":371,"activeCount":101},[],{"trials":373,"activeCount":97,"soonestReadout":326},[374],{"nctId":322,"briefTitle":323,"status":324,"phases":375,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":376,"interventions":377},[91,92],[331,332,333,334,335,336],[311,311,338,339,340,341],{"trials":379,"activeCount":101},[],{"trials":381,"activeCount":101},[],{"intervention":340,"totalTrials":97,"cells":383},{"EARLY_PHASE1":384,"PHASE1":386,"PHASE2":388,"PHASE3":390,"PHASE4":396,"NA":398},{"trials":385,"activeCount":101},[],{"trials":387,"activeCount":101},[],{"trials":389,"activeCount":101},[],{"trials":391,"activeCount":97,"soonestReadout":326},[392],{"nctId":322,"briefTitle":323,"status":324,"phases":393,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":394,"interventions":395},[91,92],[331,332,333,334,335,336],[311,311,338,339,340,341],{"trials":397,"activeCount":101},[],{"trials":399,"activeCount":101},[],{"intervention":341,"totalTrials":97,"cells":401},{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":414,"NA":416},{"trials":403,"activeCount":101},[],{"trials":405,"activeCount":101},[],{"trials":407,"activeCount":101},[],{"trials":409,"activeCount":97,"soonestReadout":326},[410],{"nctId":322,"briefTitle":323,"status":324,"phases":411,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":412,"interventions":413},[91,92],[331,332,333,334,335,336],[311,311,338,339,340,341],{"trials":415,"activeCount":101},[],{"trials":417,"activeCount":101},[],{"intervention":42,"totalTrials":97,"cells":419},{"EARLY_PHASE1":420,"PHASE1":422,"PHASE2":424,"PHASE3":426,"PHASE4":436,"NA":438},{"trials":421,"activeCount":101},[],{"trials":423,"activeCount":101},[],{"trials":425,"activeCount":101},[],{"trials":427,"activeCount":97,"soonestReadout":41},[428],{"nctId":39,"briefTitle":40,"status":111,"phases":429,"primaryCompletion":41,"completion":430,"start":431,"enrollment":432,"conditions":433,"interventions":435},[91,92],"2029-04-30","2019-11-19",34,[434],"Chronic Obstructive Pulmonary Disease Severe",[42],{"trials":437,"activeCount":101},[],{"trials":439,"activeCount":101},[],{"intervention":441,"totalTrials":97,"cells":442},"Povidone-iodine",{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":449,"PHASE4":461,"NA":463},{"trials":444,"activeCount":101},[],{"trials":446,"activeCount":101},[],{"trials":448,"activeCount":101},[],{"trials":450,"activeCount":97,"soonestReadout":86},[451],{"nctId":452,"briefTitle":453,"status":111,"phases":454,"primaryCompletion":86,"completion":86,"start":455,"enrollment":456,"conditions":457,"interventions":459},"NCT06302335","Povidone-iodine vs Saline Solution in Colorectal Surgeries and Its Effects on the Surgical Site Infection",[92],"2023-01-02",228,[458],"Surgical Site Infection",[441,460],"Saline solution",{"trials":462,"activeCount":101},[],{"trials":464,"activeCount":101},[],{"intervention":57,"totalTrials":97,"cells":466},{"EARLY_PHASE1":467,"PHASE1":469,"PHASE2":471,"PHASE3":473,"PHASE4":485,"NA":487},{"trials":468,"activeCount":101},[],{"trials":470,"activeCount":101},[],{"trials":472,"activeCount":101},[],{"trials":474,"activeCount":97,"soonestReadout":56},[475],{"nctId":54,"briefTitle":55,"status":324,"phases":476,"primaryCompletion":56,"completion":477,"start":478,"enrollment":479,"conditions":480,"interventions":483},[92],"2026-11-24","2024-05-24",99,[481,482],"Heart Failure, Systolic","Iron Deficiencies",[57,484],"Dapagliflozin 10mg Tab",{"trials":486,"activeCount":101},[],{"trials":488,"activeCount":101},[],{"intervention":484,"totalTrials":97,"cells":490},{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":503,"NA":505},{"trials":492,"activeCount":101},[],{"trials":494,"activeCount":101},[],{"trials":496,"activeCount":101},[],{"trials":498,"activeCount":97,"soonestReadout":56},[499],{"nctId":54,"briefTitle":55,"status":324,"phases":500,"primaryCompletion":56,"completion":477,"start":478,"enrollment":479,"conditions":501,"interventions":502},[92],[481,482],[57,484],{"trials":504,"activeCount":101},[],{"trials":506,"activeCount":101},[],{"intervention":460,"totalTrials":508,"cells":509},2,{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":514,"PHASE3":516,"PHASE4":522,"NA":524},{"trials":511,"activeCount":101},[],{"trials":513,"activeCount":101},[],{"trials":515,"activeCount":101},[],{"trials":517,"activeCount":97,"soonestReadout":86},[518],{"nctId":452,"briefTitle":453,"status":111,"phases":519,"primaryCompletion":86,"completion":86,"start":455,"enrollment":456,"conditions":520,"interventions":521},[92],[458],[441,460],{"trials":523,"activeCount":101},[],{"trials":525,"activeCount":101},[526],{"nctId":527,"briefTitle":528,"status":529,"phases":530,"primaryCompletion":531,"completion":532,"start":533,"enrollment":534,"conditions":535,"interventions":536},"NCT00810563","Does Bupivacaine in Laparoscopic Portals Reduce Post Surgery Pain in Tubal Ligation by Electrocoagulation?","UNKNOWN",[94],"2009-03","2009-08","2008-08",46,[29],[460,537],"Bupivacaine",{"intervention":77,"totalTrials":97,"cells":539},{"EARLY_PHASE1":540,"PHASE1":542,"PHASE2":544,"PHASE3":553,"PHASE4":555,"NA":557},{"trials":541,"activeCount":101},[],{"trials":543,"activeCount":101},[],{"trials":545,"activeCount":97,"soonestReadout":76},[546],{"nctId":74,"briefTitle":75,"status":324,"phases":547,"primaryCompletion":76,"completion":86,"start":548,"enrollment":549,"conditions":550,"interventions":552},[91],"2025-04-01",98,[551],"Acute Myeloid Leukaemia (AML)",[77],{"trials":554,"activeCount":101},[],{"trials":556,"activeCount":101},[],{"trials":558,"activeCount":101},[],{"intervention":47,"totalTrials":97,"cells":560},{"EARLY_PHASE1":561,"PHASE1":563,"PHASE2":565,"PHASE3":574,"PHASE4":576,"NA":578},{"trials":562,"activeCount":101},[],{"trials":564,"activeCount":101},[],{"trials":566,"activeCount":97,"soonestReadout":46},[567],{"nctId":44,"briefTitle":45,"status":111,"phases":568,"primaryCompletion":46,"completion":569,"start":570,"enrollment":571,"conditions":572,"interventions":573},[91],"2025-12","2021-06-12",94,[26],[47],{"trials":575,"activeCount":101},[],{"trials":577,"activeCount":101},[],{"trials":579,"activeCount":101},[],{"intervention":82,"totalTrials":97,"cells":581},{"EARLY_PHASE1":582,"PHASE1":584,"PHASE2":586,"PHASE3":596,"PHASE4":598,"NA":600},{"trials":583,"activeCount":101},[],{"trials":585,"activeCount":101},[],{"trials":587,"activeCount":97,"soonestReadout":81},[588],{"nctId":79,"briefTitle":80,"status":111,"phases":589,"primaryCompletion":81,"completion":590,"start":591,"enrollment":534,"conditions":592,"interventions":594},[90,91],"2028-12","2024-09-03",[593],"Oral Erosive Lichen Planus",[82,595],"tacrolimus ointment 0.1%",{"trials":597,"activeCount":101},[],{"trials":599,"activeCount":101},[],{"trials":601,"activeCount":101},[],{"intervention":595,"totalTrials":97,"cells":603},{"EARLY_PHASE1":604,"PHASE1":606,"PHASE2":608,"PHASE3":614,"PHASE4":616,"NA":618},{"trials":605,"activeCount":101},[],{"trials":607,"activeCount":101},[],{"trials":609,"activeCount":97,"soonestReadout":81},[610],{"nctId":79,"briefTitle":80,"status":111,"phases":611,"primaryCompletion":81,"completion":590,"start":591,"enrollment":534,"conditions":612,"interventions":613},[90,91],[593],[82,595],{"trials":615,"activeCount":101},[],{"trials":617,"activeCount":101},[],{"trials":619,"activeCount":101},[],{"intervention":621,"totalTrials":97,"cells":622},"Tocilizumab",{"EARLY_PHASE1":623,"PHASE1":625,"PHASE2":627,"PHASE3":639,"PHASE4":641,"NA":643},{"trials":624,"activeCount":101},[],{"trials":626,"activeCount":101},[],{"trials":628,"activeCount":97,"soonestReadout":327},[629],{"nctId":630,"briefTitle":631,"status":324,"phases":632,"primaryCompletion":327,"completion":327,"start":633,"enrollment":634,"conditions":635,"interventions":637},"NCT07052058","Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)",[91],"2026-07-01",32,[636],"Treatment-Resistant Major Depressive Disorder",[621,638],"Normal Saline",{"trials":640,"activeCount":101},[],{"trials":642,"activeCount":101},[],{"trials":644,"activeCount":101},[],{"intervention":638,"totalTrials":97,"cells":646},{"EARLY_PHASE1":647,"PHASE1":649,"PHASE2":651,"PHASE3":657,"PHASE4":659,"NA":661},{"trials":648,"activeCount":101},[],{"trials":650,"activeCount":101},[],{"trials":652,"activeCount":97,"soonestReadout":327},[653],{"nctId":630,"briefTitle":631,"status":324,"phases":654,"primaryCompletion":327,"completion":327,"start":633,"enrollment":634,"conditions":655,"interventions":656},[91],[636],[621,638],{"trials":658,"activeCount":101},[],{"trials":660,"activeCount":101},[],{"trials":662,"activeCount":101},[],{"intervention":664,"totalTrials":97,"cells":665},"Duloxetine (60 mg) once daily",{"EARLY_PHASE1":666,"PHASE1":668,"PHASE2":670,"PHASE3":672,"PHASE4":674,"NA":676},{"trials":667,"activeCount":101},[],{"trials":669,"activeCount":101},[],{"trials":671,"activeCount":101},[],{"trials":673,"activeCount":101},[],{"trials":675,"activeCount":101},[],{"trials":677,"activeCount":97,"soonestReadout":590},[678],{"nctId":679,"briefTitle":680,"status":111,"phases":681,"primaryCompletion":590,"completion":590,"start":682,"enrollment":683,"conditions":684,"interventions":690},"NCT07203339","Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)",[94],"2025-09-30",610,[685,686,687,688,689],"Fibromyalgia (FM)","tDCS","Duloxetine","BDNF","EEG",[664,691],"Duloxetine 60 mg",{"intervention":691,"totalTrials":97,"cells":693},{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":698,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":695,"activeCount":101},[],{"trials":697,"activeCount":101},[],{"trials":699,"activeCount":101},[],{"trials":701,"activeCount":101},[],{"trials":703,"activeCount":101},[],{"trials":705,"activeCount":97,"soonestReadout":590},[706],{"nctId":679,"briefTitle":680,"status":111,"phases":707,"primaryCompletion":590,"completion":590,"start":682,"enrollment":683,"conditions":708,"interventions":709},[94],[685,686,687,688,689],[664,691],{"intervention":711,"totalTrials":508,"cells":712},"Rhodiola",{"EARLY_PHASE1":713,"PHASE1":715,"PHASE2":717,"PHASE3":719,"PHASE4":721,"NA":739},{"trials":714,"activeCount":101},[],{"trials":716,"activeCount":101},[],{"trials":718,"activeCount":101},[],{"trials":720,"activeCount":101},[],{"trials":722,"activeCount":101},[723,732],{"nctId":724,"briefTitle":725,"status":529,"phases":726,"primaryCompletion":727,"completion":727,"start":728,"enrollment":729,"conditions":730,"interventions":731},"NCT02737033","Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit\u002FHyperactivity Disorder",[93],"2021-03","2016-04",60,[35],[711],{"nctId":733,"briefTitle":734,"status":529,"phases":735,"primaryCompletion":727,"completion":727,"start":728,"enrollment":729,"conditions":736,"interventions":738},"NCT02737020","Rhodiola Rosea in Adults With Attention Deficit\u002FHyperactivity Disorder",[93],[737],"Attention Deficit\u002FHyperactivity Disorder",[711],{"trials":740,"activeCount":101},[],{"intervention":742,"totalTrials":508,"cells":743},"quetiapine",{"EARLY_PHASE1":744,"PHASE1":746,"PHASE2":748,"PHASE3":750,"PHASE4":760,"NA":777},{"trials":745,"activeCount":101},[],{"trials":747,"activeCount":101},[],{"trials":749,"activeCount":101},[],{"trials":751,"activeCount":101},[752],{"nctId":753,"briefTitle":754,"status":529,"phases":755,"primaryCompletion":756,"completion":756,"start":531,"enrollment":202,"conditions":757,"interventions":759},"NCT00879307","Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR",[92],"2011-09",[758],"BIPOLAR DISORDER",[742],{"trials":761,"activeCount":101},[762],{"nctId":763,"briefTitle":764,"status":529,"phases":765,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":770,"interventions":772},"NCT02562287","Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder",[93],"2019-06","2020-12","2015-10",54,[771],"Bipolar Disorder",[773,774,775,776],"Clozapine","Risperidone","Olanzapine","Quetiapine",{"trials":778,"activeCount":101},[],{"intervention":780,"totalTrials":97,"cells":781},"Misoprostol 400mcg Tab",{"EARLY_PHASE1":782,"PHASE1":784,"PHASE2":786,"PHASE3":788,"PHASE4":790,"NA":805},{"trials":783,"activeCount":101},[],{"trials":785,"activeCount":101},[],{"trials":787,"activeCount":101},[],{"trials":789,"activeCount":101},[],{"trials":791,"activeCount":101},[792],{"nctId":793,"briefTitle":794,"status":795,"phases":796,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":803},"NCT02957305","Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage","COMPLETED",[93],"2019-10-19","2020-06-30","2016-12-21",211,[802],"Miscarriage in First Trimester",[780,804],"Misoprostol 200mcg Tab",{"trials":806,"activeCount":101},[],{"intervention":804,"totalTrials":97,"cells":808},{"EARLY_PHASE1":809,"PHASE1":811,"PHASE2":813,"PHASE3":815,"PHASE4":817,"NA":823},{"trials":810,"activeCount":101},[],{"trials":812,"activeCount":101},[],{"trials":814,"activeCount":101},[],{"trials":816,"activeCount":101},[],{"trials":818,"activeCount":101},[819],{"nctId":793,"briefTitle":794,"status":795,"phases":820,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":821,"interventions":822},[93],[802],[780,804],{"trials":824,"activeCount":101},[],{"intervention":826,"totalTrials":97,"cells":827},"Resveratrol",{"EARLY_PHASE1":828,"PHASE1":830,"PHASE2":832,"PHASE3":834,"PHASE4":836,"NA":847},{"trials":829,"activeCount":101},[],{"trials":831,"activeCount":101},[],{"trials":833,"activeCount":101},[],{"trials":835,"activeCount":101},[],{"trials":837,"activeCount":101},[838],{"nctId":839,"briefTitle":840,"status":795,"phases":841,"primaryCompletion":842,"completion":842,"start":843,"enrollment":8,"conditions":844,"interventions":846},"NCT02475564","Resveratrol for Pain Due to Endometriosis",[93],"2015-11","2015-06",[845],"Endometriosis",[826],{"trials":848,"activeCount":101},[],{"intervention":850,"totalTrials":97,"cells":851},"Tacrolimus",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":860,"NA":873},{"trials":853,"activeCount":101},[],{"trials":855,"activeCount":101},[],{"trials":857,"activeCount":101},[],{"trials":859,"activeCount":101},[],{"trials":861,"activeCount":101},[862],{"nctId":863,"briefTitle":864,"status":529,"phases":865,"primaryCompletion":866,"completion":866,"start":867,"enrollment":868,"conditions":869,"interventions":871},"NCT01608412","A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus",[93],"2014-07","2012-02",120,[870],"Kidney Transplant Recipients",[850,872],"Everolimus",{"trials":874,"activeCount":101},[],{"intervention":872,"totalTrials":97,"cells":876},{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":885,"NA":891},{"trials":878,"activeCount":101},[],{"trials":880,"activeCount":101},[],{"trials":882,"activeCount":101},[],{"trials":884,"activeCount":101},[],{"trials":886,"activeCount":101},[887],{"nctId":863,"briefTitle":864,"status":529,"phases":888,"primaryCompletion":866,"completion":866,"start":867,"enrollment":868,"conditions":889,"interventions":890},[93],[870],[850,872],{"trials":892,"activeCount":101},[],{"intervention":894,"totalTrials":97,"cells":895},"Alcohol N-acetylcysteine",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":920},{"trials":897,"activeCount":101},[],{"trials":899,"activeCount":101},[],{"trials":901,"activeCount":101},[],{"trials":903,"activeCount":101},[],{"trials":905,"activeCount":101},[906],{"nctId":907,"briefTitle":908,"status":529,"phases":909,"primaryCompletion":910,"completion":911,"start":912,"enrollment":202,"conditions":913,"interventions":916},"NCT03018236","Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.",[93],"2018-07","2018-12","2017-01",[914,915],"Cocaine Addiction","Alcohol Addiction",[894,917,918,919],"Alcohol Placebo","Cocaine N-acetylcysteine","Cocaine Placebo",{"trials":921,"activeCount":101},[],{"intervention":917,"totalTrials":97,"cells":923},{"EARLY_PHASE1":924,"PHASE1":926,"PHASE2":928,"PHASE3":930,"PHASE4":932,"NA":938},{"trials":925,"activeCount":101},[],{"trials":927,"activeCount":101},[],{"trials":929,"activeCount":101},[],{"trials":931,"activeCount":101},[],{"trials":933,"activeCount":101},[934],{"nctId":907,"briefTitle":908,"status":529,"phases":935,"primaryCompletion":910,"completion":911,"start":912,"enrollment":202,"conditions":936,"interventions":937},[93],[914,915],[894,917,918,919],{"trials":939,"activeCount":101},[],{"intervention":918,"totalTrials":97,"cells":941},{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":946,"PHASE3":948,"PHASE4":950,"NA":956},{"trials":943,"activeCount":101},[],{"trials":945,"activeCount":101},[],{"trials":947,"activeCount":101},[],{"trials":949,"activeCount":101},[],{"trials":951,"activeCount":101},[952],{"nctId":907,"briefTitle":908,"status":529,"phases":953,"primaryCompletion":910,"completion":911,"start":912,"enrollment":202,"conditions":954,"interventions":955},[93],[914,915],[894,917,918,919],{"trials":957,"activeCount":101},[],{"intervention":919,"totalTrials":97,"cells":959},{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":974},{"trials":961,"activeCount":101},[],{"trials":963,"activeCount":101},[],{"trials":965,"activeCount":101},[],{"trials":967,"activeCount":101},[],{"trials":969,"activeCount":101},[970],{"nctId":907,"briefTitle":908,"status":529,"phases":971,"primaryCompletion":910,"completion":911,"start":912,"enrollment":202,"conditions":972,"interventions":973},[93],[914,915],[894,917,918,919],{"trials":975,"activeCount":101},[],{"intervention":977,"totalTrials":97,"cells":978},"Azithromycin",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":987,"NA":999},{"trials":980,"activeCount":101},[],{"trials":982,"activeCount":101},[],{"trials":984,"activeCount":101},[],{"trials":986,"activeCount":101},[],{"trials":988,"activeCount":101},[989],{"nctId":990,"briefTitle":991,"status":795,"phases":992,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":996,"interventions":998},"NCT03485703","Azithromycin in the Prevention of Lung Injury in Premature Newborn",[93],"2016-04-13","2012-08-28",80,[997],"Bronchopulmonary Dysplasia",[977],{"trials":1000,"activeCount":101},[],{"intervention":1002,"totalTrials":97,"cells":1003},"Topiramate",{"EARLY_PHASE1":1004,"PHASE1":1006,"PHASE2":1008,"PHASE3":1010,"PHASE4":1012,"NA":1024},{"trials":1005,"activeCount":101},[],{"trials":1007,"activeCount":101},[],{"trials":1009,"activeCount":101},[],{"trials":1011,"activeCount":101},[],{"trials":1013,"activeCount":101},[1014],{"nctId":1015,"briefTitle":1016,"status":529,"phases":1017,"primaryCompletion":1018,"completion":1018,"start":1019,"enrollment":995,"conditions":1020,"interventions":1023},"NCT04453306","Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome",[93],"2021-12","2014-05",[24,1021,1022],"Polycystic Ovary Syndrome","Hyperandrogenism",[1002],{"trials":1025,"activeCount":101},[],{"intervention":1027,"totalTrials":97,"cells":1028},"rFSH",{"EARLY_PHASE1":1029,"PHASE1":1031,"PHASE2":1033,"PHASE3":1035,"PHASE4":1037,"NA":1050},{"trials":1030,"activeCount":101},[],{"trials":1032,"activeCount":101},[],{"trials":1034,"activeCount":101},[],{"trials":1036,"activeCount":101},[],{"trials":1038,"activeCount":101},[1039],{"nctId":1040,"briefTitle":1041,"status":795,"phases":1042,"primaryCompletion":1043,"completion":1043,"start":1044,"enrollment":1045,"conditions":1046,"interventions":1048},"NCT02412904","Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist",[93],"2014-12","2014-01",188,[1047],"Infertility",[1027,1049],"HMG",{"trials":1051,"activeCount":101},[],{"intervention":1049,"totalTrials":97,"cells":1053},{"EARLY_PHASE1":1054,"PHASE1":1056,"PHASE2":1058,"PHASE3":1060,"PHASE4":1062,"NA":1068},{"trials":1055,"activeCount":101},[],{"trials":1057,"activeCount":101},[],{"trials":1059,"activeCount":101},[],{"trials":1061,"activeCount":101},[],{"trials":1063,"activeCount":101},[1064],{"nctId":1040,"briefTitle":1041,"status":795,"phases":1065,"primaryCompletion":1043,"completion":1043,"start":1044,"enrollment":1045,"conditions":1066,"interventions":1067},[93],[1047],[1027,1049],{"trials":1069,"activeCount":101},[],{"intervention":1071,"totalTrials":97,"cells":1072},"Simvastatin 40mg",{"EARLY_PHASE1":1073,"PHASE1":1075,"PHASE2":1077,"PHASE3":1079,"PHASE4":1081,"NA":1092},{"trials":1074,"activeCount":101},[],{"trials":1076,"activeCount":101},[],{"trials":1078,"activeCount":101},[],{"trials":1080,"activeCount":101},[],{"trials":1082,"activeCount":101},[1083],{"nctId":1084,"briefTitle":1085,"status":529,"phases":1086,"primaryCompletion":1087,"completion":1087,"start":1088,"enrollment":1089,"conditions":1090,"interventions":1091},"NCT00704548","Antihypertensive Effect of Simvastatin in Hypertensive Patients",[93],"2009-09","2008-06",92,[15],[1071],{"trials":1093,"activeCount":101},[],{"intervention":1095,"totalTrials":97,"cells":1096},"methylphenidate",{"EARLY_PHASE1":1097,"PHASE1":1099,"PHASE2":1101,"PHASE3":1103,"PHASE4":1105,"NA":1117},{"trials":1098,"activeCount":101},[],{"trials":1100,"activeCount":101},[],{"trials":1102,"activeCount":101},[],{"trials":1104,"activeCount":101},[],{"trials":1106,"activeCount":101},[1107],{"nctId":1108,"briefTitle":1109,"status":795,"phases":1110,"primaryCompletion":1111,"completion":1111,"start":1112,"enrollment":1113,"conditions":1114,"interventions":1116},"NCT01228604","Cost-Effectiveness Study Of The Treatment Of Attention Deficit\u002FHyperactivity Disorder In Brazil",[93],"2013-12","2010-12",23,[1115],"Attention-deficit\u002FHyperactivity Disorder",[1095],{"trials":1118,"activeCount":101},[],{"intervention":1120,"totalTrials":97,"cells":1121},"MET + Vildagliptin Group",{"EARLY_PHASE1":1122,"PHASE1":1124,"PHASE2":1126,"PHASE3":1128,"PHASE4":1130,"NA":1145},{"trials":1123,"activeCount":101},[],{"trials":1125,"activeCount":101},[],{"trials":1127,"activeCount":101},[],{"trials":1129,"activeCount":101},[],{"trials":1131,"activeCount":101},[1132],{"nctId":1133,"briefTitle":1134,"status":529,"phases":1135,"primaryCompletion":1136,"completion":1136,"start":1137,"enrollment":1138,"conditions":1139,"interventions":1143},"NCT01867502","Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes",[93],"2015-08","2014-04",20,[26,1140,1141,1142],"Hypoglycemic Agents","Diabetic Blood Glucose Monitoring","Exercise",[1120,1144],"MET + Glibenclamide Group",{"trials":1146,"activeCount":101},[],{"intervention":1144,"totalTrials":97,"cells":1148},{"EARLY_PHASE1":1149,"PHASE1":1151,"PHASE2":1153,"PHASE3":1155,"PHASE4":1157,"NA":1163},{"trials":1150,"activeCount":101},[],{"trials":1152,"activeCount":101},[],{"trials":1154,"activeCount":101},[],{"trials":1156,"activeCount":101},[],{"trials":1158,"activeCount":101},[1159],{"nctId":1133,"briefTitle":1134,"status":529,"phases":1160,"primaryCompletion":1136,"completion":1136,"start":1137,"enrollment":1138,"conditions":1161,"interventions":1162},[93],[26,1140,1141,1142],[1120,1144],{"trials":1164,"activeCount":101},[],{"intervention":1166,"totalTrials":97,"cells":1167},"metronidazole and doxycycline",{"EARLY_PHASE1":1168,"PHASE1":1170,"PHASE2":1172,"PHASE3":1174,"PHASE4":1176,"NA":1189},{"trials":1169,"activeCount":101},[],{"trials":1171,"activeCount":101},[],{"trials":1173,"activeCount":101},[],{"trials":1175,"activeCount":101},[],{"trials":1177,"activeCount":101},[1178],{"nctId":1179,"briefTitle":1180,"status":1181,"phases":1182,"primaryCompletion":1183,"completion":1183,"start":1184,"enrollment":1185,"conditions":1186,"interventions":1188},"NCT00376493","Prolonged Treatment for Infected Abortion After Hospital Discharge.","TERMINATED",[93],"2007-12","2006-05",56,[1187],"Septic Abortion",[1166],{"trials":1190,"activeCount":101},[],{"intervention":1192,"totalTrials":97,"cells":1193},"aspirin",{"EARLY_PHASE1":1194,"PHASE1":1196,"PHASE2":1198,"PHASE3":1200,"PHASE4":1202,"NA":1214},{"trials":1195,"activeCount":101},[],{"trials":1197,"activeCount":101},[],{"trials":1199,"activeCount":101},[],{"trials":1201,"activeCount":101},[],{"trials":1203,"activeCount":101},[1204],{"nctId":1205,"briefTitle":1206,"status":529,"phases":1207,"completion":1208,"start":1209,"enrollment":1138,"conditions":1210,"interventions":1213},"NCT00427271","Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients",[93],"2007-01","2003-03",[1211,1212],"Diabetes Mellitus","Microalbuminuria",[1192],{"trials":1215,"activeCount":101},[],{"intervention":1217,"totalTrials":97,"cells":1218},"Thioglycolic Acid",{"EARLY_PHASE1":1219,"PHASE1":1221,"PHASE2":1223,"PHASE3":1225,"PHASE4":1227,"NA":1240},{"trials":1220,"activeCount":101},[],{"trials":1222,"activeCount":101},[],{"trials":1224,"activeCount":101},[],{"trials":1226,"activeCount":101},[],{"trials":1228,"activeCount":101},[1229],{"nctId":1230,"briefTitle":1231,"status":529,"phases":1232,"primaryCompletion":1233,"completion":1234,"start":1235,"enrollment":1236,"conditions":1237,"interventions":1239},"NCT03238105","Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light",[93],"2020-02-10","2020-12-31","2017-08-01",29,[1238],"Periorbital Disorder",[1217],{"trials":1241,"activeCount":101},[],{"intervention":1243,"totalTrials":97,"cells":1244},"Lasilactone",{"EARLY_PHASE1":1245,"PHASE1":1247,"PHASE2":1249,"PHASE3":1251,"PHASE4":1253,"NA":1264},{"trials":1246,"activeCount":101},[],{"trials":1248,"activeCount":101},[],{"trials":1250,"activeCount":101},[],{"trials":1252,"activeCount":101},[],{"trials":1254,"activeCount":101},[1255],{"nctId":1256,"briefTitle":1257,"status":795,"phases":1258,"primaryCompletion":1259,"completion":1259,"start":1260,"enrollment":769,"conditions":1261,"interventions":1263},"NCT01945801","Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea",[93],"2015-02","2013-10",[1262],"Obstructive Sleep Apnea",[1243],{"trials":1265,"activeCount":101},[],{"intervention":1267,"totalTrials":97,"cells":1268},"L-ornithine-L-aspartate",{"EARLY_PHASE1":1269,"PHASE1":1271,"PHASE2":1273,"PHASE3":1275,"PHASE4":1277,"NA":1289},{"trials":1270,"activeCount":101},[],{"trials":1272,"activeCount":101},[],{"trials":1274,"activeCount":101},[],{"trials":1276,"activeCount":101},[],{"trials":1278,"activeCount":101},[1279],{"nctId":1280,"briefTitle":1281,"status":529,"phases":1282,"primaryCompletion":1283,"completion":1284,"start":1285,"enrollment":244,"conditions":1286,"interventions":1288},"NCT00896831","Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy",[93],"2010-03","2010-09","2008-11",[1287],"Hepatic Encephalopathy",[1267],{"trials":1290,"activeCount":101},[],{"intervention":1292,"totalTrials":97,"cells":1293},"memantine",{"EARLY_PHASE1":1294,"PHASE1":1296,"PHASE2":1298,"PHASE3":1300,"PHASE4":1302,"NA":1315},{"trials":1295,"activeCount":101},[],{"trials":1297,"activeCount":101},[],{"trials":1299,"activeCount":101},[],{"trials":1301,"activeCount":101},[],{"trials":1303,"activeCount":101},[1304],{"nctId":1305,"briefTitle":1306,"status":795,"phases":1307,"primaryCompletion":1308,"completion":1309,"start":1310,"enrollment":1311,"conditions":1312,"interventions":1314},"NCT00757978","Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms",[93],"2008-01","2008-03","2006-01",22,[1313],"Schizophrenia",[1292],{"trials":1316,"activeCount":101},[],{"intervention":1318,"totalTrials":97,"cells":1319},"Taurolidine",{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1328,"NA":1341},{"trials":1321,"activeCount":101},[],{"trials":1323,"activeCount":101},[],{"trials":1325,"activeCount":101},[],{"trials":1327,"activeCount":101},[],{"trials":1329,"activeCount":101},[1330],{"nctId":1331,"briefTitle":1332,"status":529,"phases":1333,"primaryCompletion":1334,"completion":1335,"start":1336,"enrollment":1138,"conditions":1337,"interventions":1339},"NCT02515201","Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children",[93],"2015-03","2016-12","2014-09",[1338],"Catheter-Related Infections",[1318,1340],"Heparin",{"trials":1342,"activeCount":101},[],{"intervention":1340,"totalTrials":97,"cells":1344},{"EARLY_PHASE1":1345,"PHASE1":1347,"PHASE2":1349,"PHASE3":1351,"PHASE4":1353,"NA":1359},{"trials":1346,"activeCount":101},[],{"trials":1348,"activeCount":101},[],{"trials":1350,"activeCount":101},[],{"trials":1352,"activeCount":101},[],{"trials":1354,"activeCount":101},[1355],{"nctId":1331,"briefTitle":1332,"status":529,"phases":1356,"primaryCompletion":1334,"completion":1335,"start":1336,"enrollment":1138,"conditions":1357,"interventions":1358},[93],[1338],[1318,1340],{"trials":1360,"activeCount":101},[],{"intervention":773,"totalTrials":97,"cells":1362},{"EARLY_PHASE1":1363,"PHASE1":1365,"PHASE2":1367,"PHASE3":1369,"PHASE4":1371,"NA":1377},{"trials":1364,"activeCount":101},[],{"trials":1366,"activeCount":101},[],{"trials":1368,"activeCount":101},[],{"trials":1370,"activeCount":101},[],{"trials":1372,"activeCount":101},[1373],{"nctId":763,"briefTitle":764,"status":529,"phases":1374,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":1375,"interventions":1376},[93],[771],[773,774,775,776],{"trials":1378,"activeCount":101},[],{"intervention":775,"totalTrials":97,"cells":1380},{"EARLY_PHASE1":1381,"PHASE1":1383,"PHASE2":1385,"PHASE3":1387,"PHASE4":1389,"NA":1395},{"trials":1382,"activeCount":101},[],{"trials":1384,"activeCount":101},[],{"trials":1386,"activeCount":101},[],{"trials":1388,"activeCount":101},[],{"trials":1390,"activeCount":101},[1391],{"nctId":763,"briefTitle":764,"status":529,"phases":1392,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":1393,"interventions":1394},[93],[771],[773,774,775,776],{"trials":1396,"activeCount":101},[],{"intervention":1398,"totalTrials":97,"cells":1399},"dry misoprostol",{"EARLY_PHASE1":1400,"PHASE1":1402,"PHASE2":1404,"PHASE3":1406,"PHASE4":1408,"NA":1419},{"trials":1401,"activeCount":101},[],{"trials":1403,"activeCount":101},[],{"trials":1405,"activeCount":101},[],{"trials":1407,"activeCount":101},[],{"trials":1409,"activeCount":101},[1410],{"nctId":1411,"briefTitle":1412,"status":795,"phases":1413,"primaryCompletion":1414,"completion":1414,"start":1136,"enrollment":534,"conditions":1415,"interventions":1417},"NCT02522078","Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion",[93],"2016-02",[1416],"Abortion Early",[1398,1418],"wet misoprostol",{"trials":1420,"activeCount":101},[],{"intervention":1418,"totalTrials":97,"cells":1422},{"EARLY_PHASE1":1423,"PHASE1":1425,"PHASE2":1427,"PHASE3":1429,"PHASE4":1431,"NA":1437},{"trials":1424,"activeCount":101},[],{"trials":1426,"activeCount":101},[],{"trials":1428,"activeCount":101},[],{"trials":1430,"activeCount":101},[],{"trials":1432,"activeCount":101},[1433],{"nctId":1411,"briefTitle":1412,"status":795,"phases":1434,"primaryCompletion":1414,"completion":1414,"start":1136,"enrollment":534,"conditions":1435,"interventions":1436},[93],[1416],[1398,1418],{"trials":1438,"activeCount":101},[],{"intervention":1440,"totalTrials":97,"cells":1441},"Diclofenac oral + Placebo",{"EARLY_PHASE1":1442,"PHASE1":1444,"PHASE2":1446,"PHASE3":1448,"PHASE4":1450,"NA":1462},{"trials":1443,"activeCount":101},[],{"trials":1445,"activeCount":101},[],{"trials":1447,"activeCount":101},[],{"trials":1449,"activeCount":101},[],{"trials":1451,"activeCount":101},[1452],{"nctId":1453,"briefTitle":1454,"status":529,"phases":1455,"primaryCompletion":1456,"completion":1457,"start":1235,"enrollment":1458,"conditions":1459,"interventions":1460},"NCT03506763","Effect of Pre-medication in Pain Measures on Office Hysteroscopy",[93],"2018-12-31","2019-06-30",231,[29],[1440,1461],"Diclofenac oral + scopolamina",{"trials":1463,"activeCount":101},[],{"intervention":1461,"totalTrials":97,"cells":1465},{"EARLY_PHASE1":1466,"PHASE1":1468,"PHASE2":1470,"PHASE3":1472,"PHASE4":1474,"NA":1480},{"trials":1467,"activeCount":101},[],{"trials":1469,"activeCount":101},[],{"trials":1471,"activeCount":101},[],{"trials":1473,"activeCount":101},[],{"trials":1475,"activeCount":101},[1476],{"nctId":1453,"briefTitle":1454,"status":529,"phases":1477,"primaryCompletion":1456,"completion":1457,"start":1235,"enrollment":1458,"conditions":1478,"interventions":1479},[93],[29],[1440,1461],{"trials":1481,"activeCount":101},[],{"intervention":1483,"totalTrials":97,"cells":1484},"Clindamycin",{"EARLY_PHASE1":1485,"PHASE1":1487,"PHASE2":1489,"PHASE3":1491,"PHASE4":1493,"NA":1504},{"trials":1486,"activeCount":101},[],{"trials":1488,"activeCount":101},[],{"trials":1490,"activeCount":101},[],{"trials":1492,"activeCount":101},[],{"trials":1494,"activeCount":101},[1495],{"nctId":1496,"briefTitle":1497,"status":795,"phases":1498,"primaryCompletion":1499,"completion":1499,"start":1500,"enrollment":1501,"conditions":1502,"interventions":1503},"NCT02309346","Clindamycin Once a Day in Septic Abortion",[93],"2023-12-31","2014-12-17",202,[1187],[1483],{"trials":1505,"activeCount":101},[],{"intervention":1507,"totalTrials":97,"cells":1508},"Glyburide",{"EARLY_PHASE1":1509,"PHASE1":1511,"PHASE2":1513,"PHASE3":1515,"PHASE4":1517,"NA":1527},{"trials":1510,"activeCount":101},[],{"trials":1512,"activeCount":101},[],{"trials":1514,"activeCount":101},[],{"trials":1516,"activeCount":101},[],{"trials":1518,"activeCount":101},[1519],{"nctId":1520,"briefTitle":1521,"status":529,"phases":1522,"primaryCompletion":1043,"completion":1335,"start":1044,"enrollment":995,"conditions":1523,"interventions":1525},"NCT02091336","Oral Antidiabetic Agents in Pregnancy",[93],[1524],"Gestational Diabetes",[1526,1507],"Metformin",{"trials":1528,"activeCount":101},[],{"intervention":1530,"totalTrials":97,"cells":1531},"Nitrate",{"EARLY_PHASE1":1532,"PHASE1":1534,"PHASE2":1536,"PHASE3":1538,"PHASE4":1540,"NA":1552},{"trials":1533,"activeCount":101},[],{"trials":1535,"activeCount":101},[],{"trials":1537,"activeCount":101},[],{"trials":1539,"activeCount":101},[],{"trials":1541,"activeCount":101},[1542],{"nctId":1543,"briefTitle":1544,"status":795,"phases":1545,"primaryCompletion":1111,"completion":1111,"start":1087,"enrollment":1546,"conditions":1547,"interventions":1551},"NCT01769079","Clinical Impact of the Withdrawal of Nitrate in Patients With Stable Angina",[93],95,[1548,1549,1550],"Stable Angina","Myocardial Ischemia","Quality of Life",[1530],{"trials":1553,"activeCount":101},[],{"intervention":1555,"totalTrials":1556,"cells":1557},"Chlorthalidone plus amiloride",3,{"EARLY_PHASE1":1558,"PHASE1":1560,"PHASE2":1562,"PHASE3":1564,"PHASE4":1596,"NA":1598},{"trials":1559,"activeCount":101},[],{"trials":1561,"activeCount":101},[],{"trials":1563,"activeCount":101},[],{"trials":1565,"activeCount":101},[1566,1576,1588],{"nctId":1567,"briefTitle":1568,"status":795,"phases":1569,"primaryCompletion":1336,"completion":1336,"start":1570,"enrollment":1571,"conditions":1572,"interventions":1574},"NCT00971165","Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension",[92],"2010-07",655,[15,1573],"Cardiovascular Disease",[1575,1555],"losartan",{"nctId":1577,"briefTitle":1578,"status":795,"phases":1579,"primaryCompletion":1580,"completion":1581,"start":1582,"enrollment":1583,"conditions":1584,"interventions":1586},"NCT02896621","Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea",[92],"2016-02-23","2017-02-14","2014-12-07",69,[15,1585],"Sleep Apnea",[1555,1587],"Amlodipine",{"nctId":1589,"briefTitle":1590,"status":795,"phases":1591,"primaryCompletion":1336,"completion":1336,"start":1570,"enrollment":1592,"conditions":1593,"interventions":1595},"NCT00970931","Hypertension Prevention in Pre-Hypertensive Individuals",[92],730,[1594,15,1573],"Pre-hypertension",[1555],{"trials":1597,"activeCount":101},[],{"trials":1599,"activeCount":101},[],{"intervention":1575,"totalTrials":508,"cells":1601},{"EARLY_PHASE1":1602,"PHASE1":1604,"PHASE2":1606,"PHASE3":1628,"PHASE4":1634,"NA":1636},{"trials":1603,"activeCount":101},[],{"trials":1605,"activeCount":101},[],{"trials":1607,"activeCount":101},[1608],{"nctId":1609,"briefTitle":1610,"status":529,"phases":1611,"primaryCompletion":1612,"completion":1613,"start":1614,"enrollment":1615,"conditions":1616,"interventions":1626},"NCT03632213","Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI",[91],"2023-05-04","2023-08-03","2018-11-07",10,[1617,1618,1619,1620,1621,1622,1623,1624,1625],"Mucopolysaccharidosis IV A","Mucopolysaccharidosis VI","Mucopolysaccharidoses","MPS IV A","MPS VI","MPS - Mucopolysaccharidosis","Morquio A Syndrome","Morquio Syndrome A","Morquio Syndrome",[1627],"Losartan",{"trials":1629,"activeCount":101},[1630],{"nctId":1567,"briefTitle":1568,"status":795,"phases":1631,"primaryCompletion":1336,"completion":1336,"start":1570,"enrollment":1571,"conditions":1632,"interventions":1633},[92],[15,1573],[1575,1555],{"trials":1635,"activeCount":101},[],{"trials":1637,"activeCount":101},[],{"intervention":1639,"totalTrials":508,"cells":1640},"Resfenol",{"EARLY_PHASE1":1641,"PHASE1":1643,"PHASE2":1645,"PHASE3":1647,"PHASE4":1671,"NA":1673},{"trials":1642,"activeCount":101},[],{"trials":1644,"activeCount":101},[],{"trials":1646,"activeCount":101},[],{"trials":1648,"activeCount":101},[1649,1660],{"nctId":1650,"briefTitle":1651,"status":795,"phases":1652,"primaryCompletion":756,"completion":1653,"start":1654,"enrollment":1655,"conditions":1656,"interventions":1659},"NCT01158326","Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu",[92],"2011-11","2010-08",216,[1657,1658],"Common Cold","Influenza",[1639],{"nctId":1661,"briefTitle":1662,"status":529,"phases":1663,"primaryCompletion":1664,"start":1665,"enrollment":1666,"conditions":1667,"interventions":1669},"NCT00940836","Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome",[92],"2009-11","2009-06",146,[1657,1668],"Flu-like Syndrome",[1639,1670],"Co interventional acetaminophen",{"trials":1672,"activeCount":101},[],{"trials":1674,"activeCount":101},[],{"intervention":1676,"totalTrials":508,"cells":1677},"Pregabalin",{"EARLY_PHASE1":1678,"PHASE1":1680,"PHASE2":1682,"PHASE3":1691,"PHASE4":1700,"NA":1702},{"trials":1679,"activeCount":101},[],{"trials":1681,"activeCount":101},[],{"trials":1683,"activeCount":101},[1684],{"nctId":1685,"briefTitle":1686,"status":529,"phases":1687,"primaryCompletion":866,"completion":1043,"start":1688,"enrollment":432,"conditions":1689,"interventions":1690},"NCT01904097","Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS",[91],"2013-03",[18,32],[1676],{"trials":1692,"activeCount":101},[1693],{"nctId":1694,"briefTitle":1695,"status":795,"phases":1696,"primaryCompletion":912,"completion":912,"start":1043,"enrollment":1697,"conditions":1698,"interventions":1699},"NCT02639533","Brain Response to Single Dose of Pregabalin in Fibromyalgia",[91,92],27,[18],[1676],{"trials":1701,"activeCount":101},[],{"trials":1703,"activeCount":101},[],{"intervention":1705,"totalTrials":97,"cells":1706},"Folinic Acid",{"EARLY_PHASE1":1707,"PHASE1":1709,"PHASE2":1711,"PHASE3":1713,"PHASE4":1726,"NA":1728},{"trials":1708,"activeCount":101},[],{"trials":1710,"activeCount":101},[],{"trials":1712,"activeCount":101},[],{"trials":1714,"activeCount":101},[1715],{"nctId":1716,"briefTitle":1717,"status":795,"phases":1718,"primaryCompletion":1719,"completion":1720,"start":1721,"enrollment":1583,"conditions":1722,"interventions":1725},"NCT02810275","Folinic Acid: Supplementation and Therapy",[92],"2013-07","2013-09","2012-10",[1723,1724],"HIV Infection","HCV Coinfection",[1705],{"trials":1727,"activeCount":101},[],{"trials":1729,"activeCount":101},[],{"intervention":1731,"totalTrials":97,"cells":1732},"L-arginine",{"EARLY_PHASE1":1733,"PHASE1":1735,"PHASE2":1737,"PHASE3":1739,"PHASE4":1751,"NA":1753},{"trials":1734,"activeCount":101},[],{"trials":1736,"activeCount":101},[],{"trials":1738,"activeCount":101},[],{"trials":1740,"activeCount":101},[1741],{"nctId":1742,"briefTitle":1743,"status":795,"phases":1744,"primaryCompletion":1308,"completion":1745,"start":1746,"enrollment":1747,"conditions":1748,"interventions":1750},"NCT01142219","L-Arginine and Sickle Cell Disease",[92],"2009-10","2006-09",40,[1749],"Sickle Cell Disease",[1731],{"trials":1752,"activeCount":101},[],{"trials":1754,"activeCount":101},[],{"intervention":1756,"totalTrials":97,"cells":1757},"Diuretics",{"EARLY_PHASE1":1758,"PHASE1":1760,"PHASE2":1762,"PHASE3":1764,"PHASE4":1775,"NA":1777},{"trials":1759,"activeCount":101},[],{"trials":1761,"activeCount":101},[],{"trials":1763,"activeCount":101},[],{"trials":1765,"activeCount":101},[1766],{"nctId":1767,"briefTitle":1768,"status":795,"phases":1769,"primaryCompletion":1770,"completion":1414,"start":1043,"enrollment":1771,"conditions":1772,"interventions":1773},"NCT01896661","Effect of Antihypertensive Agents Over Sleep Apnea",[92],"2015-12",53,[15,1262],[1756,1774],"Calcium Channel Blockers",{"trials":1776,"activeCount":101},[],{"trials":1778,"activeCount":101},[],{"intervention":1774,"totalTrials":97,"cells":1780},{"EARLY_PHASE1":1781,"PHASE1":1783,"PHASE2":1785,"PHASE3":1787,"PHASE4":1793,"NA":1795},{"trials":1782,"activeCount":101},[],{"trials":1784,"activeCount":101},[],{"trials":1786,"activeCount":101},[],{"trials":1788,"activeCount":101},[1789],{"nctId":1767,"briefTitle":1768,"status":795,"phases":1790,"primaryCompletion":1770,"completion":1414,"start":1043,"enrollment":1771,"conditions":1791,"interventions":1792},[92],[15,1262],[1756,1774],{"trials":1794,"activeCount":101},[],{"trials":1796,"activeCount":101},[],{"intervention":1798,"totalTrials":97,"cells":1799},"Prolonged Cefepime",{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1804,"PHASE3":1806,"PHASE4":1820,"NA":1822},{"trials":1801,"activeCount":101},[],{"trials":1803,"activeCount":101},[],{"trials":1805,"activeCount":101},[],{"trials":1807,"activeCount":101},[1808],{"nctId":1809,"briefTitle":1810,"status":529,"phases":1811,"primaryCompletion":1812,"completion":1813,"start":768,"enrollment":1814,"conditions":1815,"interventions":1818},"NCT02568800","Prolonged Infusion Cefepime and Nosocomial Infections",[92],"2016-03","2016-09",134,[1816,1817],"Urinary Tract Infection","Respiratory Tract Infection",[1798,1819],"Usual Cefepime",{"trials":1821,"activeCount":101},[],{"trials":1823,"activeCount":101},[],{"intervention":1819,"totalTrials":97,"cells":1825},{"EARLY_PHASE1":1826,"PHASE1":1828,"PHASE2":1830,"PHASE3":1832,"PHASE4":1838,"NA":1840},{"trials":1827,"activeCount":101},[],{"trials":1829,"activeCount":101},[],{"trials":1831,"activeCount":101},[],{"trials":1833,"activeCount":101},[1834],{"nctId":1809,"briefTitle":1810,"status":529,"phases":1835,"primaryCompletion":1812,"completion":1813,"start":768,"enrollment":1814,"conditions":1836,"interventions":1837},[92],[1816,1817],[1798,1819],{"trials":1839,"activeCount":101},[],{"trials":1841,"activeCount":101},[],{"intervention":1843,"totalTrials":97,"cells":1844},"Amoxicillin, Clarythromycin, Omeprazole for ten days",{"EARLY_PHASE1":1845,"PHASE1":1847,"PHASE2":1849,"PHASE3":1851,"PHASE4":1862,"NA":1864},{"trials":1846,"activeCount":101},[],{"trials":1848,"activeCount":101},[],{"trials":1850,"activeCount":101},[],{"trials":1852,"activeCount":101},[1853],{"nctId":1854,"briefTitle":1855,"status":795,"phases":1856,"primaryCompletion":1665,"completion":1665,"start":1857,"enrollment":1858,"conditions":1859,"interventions":1861},"NCT00404534","Helicobacter Eradication Relief of Dyspeptic Symptoms",[92],"2006-10",407,[1860],"Functional Dyspepsia",[1843],{"trials":1863,"activeCount":101},[],{"trials":1865,"activeCount":101},[],{"intervention":1867,"totalTrials":97,"cells":1868},"Epoetin Alfa-BioManguinhos",{"EARLY_PHASE1":1869,"PHASE1":1871,"PHASE2":1873,"PHASE3":1875,"PHASE4":1889,"NA":1891},{"trials":1870,"activeCount":101},[],{"trials":1872,"activeCount":101},[],{"trials":1874,"activeCount":101},[],{"trials":1876,"activeCount":101},[1877],{"nctId":1878,"briefTitle":1879,"status":795,"phases":1880,"primaryCompletion":1881,"completion":1882,"start":1883,"enrollment":1884,"conditions":1885,"interventions":1887},"NCT01184495","Efficacy Study of Two Formulations of Erythropoietin",[92],"2008-12","2009-01","2008-04",74,[1886],"Comparison of the Efficacy of Two Formulations of Epoetin in Patients Undergoing Hemodialysis",[1867,1888],"Epoetin Alfa-BioSimilar",{"trials":1890,"activeCount":101},[],{"trials":1892,"activeCount":101},[],{"intervention":1888,"totalTrials":97,"cells":1894},{"EARLY_PHASE1":1895,"PHASE1":1897,"PHASE2":1899,"PHASE3":1901,"PHASE4":1907,"NA":1909},{"trials":1896,"activeCount":101},[],{"trials":1898,"activeCount":101},[],{"trials":1900,"activeCount":101},[],{"trials":1902,"activeCount":101},[1903],{"nctId":1878,"briefTitle":1879,"status":795,"phases":1904,"primaryCompletion":1881,"completion":1882,"start":1883,"enrollment":1884,"conditions":1905,"interventions":1906},[92],[1886],[1867,1888],{"trials":1908,"activeCount":101},[],{"trials":1910,"activeCount":101},[],{"intervention":1912,"totalTrials":97,"cells":1913},"Amantadine",{"EARLY_PHASE1":1914,"PHASE1":1916,"PHASE2":1918,"PHASE3":1920,"PHASE4":1929,"NA":1931},{"trials":1915,"activeCount":101},[],{"trials":1917,"activeCount":101},[],{"trials":1919,"activeCount":101},[],{"trials":1921,"activeCount":101},[1922],{"nctId":1923,"briefTitle":1924,"status":529,"phases":1925,"primaryCompletion":756,"completion":756,"start":1926,"enrollment":1747,"conditions":1927,"interventions":1928},"NCT00999505","Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia",[92],"2010-05",[1313],[1912],{"trials":1930,"activeCount":101},[],{"trials":1932,"activeCount":101},[],{"intervention":1934,"totalTrials":97,"cells":1935},"Chlorthalidone 25 mg",{"EARLY_PHASE1":1936,"PHASE1":1938,"PHASE2":1940,"PHASE3":1942,"PHASE4":1956,"NA":1958},{"trials":1937,"activeCount":101},[],{"trials":1939,"activeCount":101},[],{"trials":1941,"activeCount":101},[],{"trials":1943,"activeCount":101},[1944],{"nctId":1945,"briefTitle":1946,"status":529,"phases":1947,"primaryCompletion":1948,"completion":1948,"start":1949,"enrollment":1950,"conditions":1951,"interventions":1952},"NCT03928145","Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.",[92],"2021-07","2019-11-13",84,[15],[1934,1953,1954,1955],"Hydrochlorothiazide 50 mg","Amiloride 20 mg","Amiloride 10 mg",{"trials":1957,"activeCount":101},[],{"trials":1959,"activeCount":101},[],{"intervention":1953,"totalTrials":97,"cells":1961},{"EARLY_PHASE1":1962,"PHASE1":1964,"PHASE2":1966,"PHASE3":1968,"PHASE4":1974,"NA":1976},{"trials":1963,"activeCount":101},[],{"trials":1965,"activeCount":101},[],{"trials":1967,"activeCount":101},[],{"trials":1969,"activeCount":101},[1970],{"nctId":1945,"briefTitle":1946,"status":529,"phases":1971,"primaryCompletion":1948,"completion":1948,"start":1949,"enrollment":1950,"conditions":1972,"interventions":1973},[92],[15],[1934,1953,1954,1955],{"trials":1975,"activeCount":101},[],{"trials":1977,"activeCount":101},[],{"intervention":1954,"totalTrials":97,"cells":1979},{"EARLY_PHASE1":1980,"PHASE1":1982,"PHASE2":1984,"PHASE3":1986,"PHASE4":1992,"NA":1994},{"trials":1981,"activeCount":101},[],{"trials":1983,"activeCount":101},[],{"trials":1985,"activeCount":101},[],{"trials":1987,"activeCount":101},[1988],{"nctId":1945,"briefTitle":1946,"status":529,"phases":1989,"primaryCompletion":1948,"completion":1948,"start":1949,"enrollment":1950,"conditions":1990,"interventions":1991},[92],[15],[1934,1953,1954,1955],{"trials":1993,"activeCount":101},[],{"trials":1995,"activeCount":101},[],{"intervention":1955,"totalTrials":97,"cells":1997},{"EARLY_PHASE1":1998,"PHASE1":2000,"PHASE2":2002,"PHASE3":2004,"PHASE4":2010,"NA":2012},{"trials":1999,"activeCount":101},[],{"trials":2001,"activeCount":101},[],{"trials":2003,"activeCount":101},[],{"trials":2005,"activeCount":101},[2006],{"nctId":1945,"briefTitle":1946,"status":529,"phases":2007,"primaryCompletion":1948,"completion":1948,"start":1949,"enrollment":1950,"conditions":2008,"interventions":2009},[92],[15],[1934,1953,1954,1955],{"trials":2011,"activeCount":101},[],{"trials":2013,"activeCount":101},[],{"intervention":2015,"totalTrials":97,"cells":2016},"Active",{"EARLY_PHASE1":2017,"PHASE1":2019,"PHASE2":2021,"PHASE3":2023,"PHASE4":2034,"NA":2036},{"trials":2018,"activeCount":101},[],{"trials":2020,"activeCount":101},[],{"trials":2022,"activeCount":101},[],{"trials":2024,"activeCount":101},[2025],{"nctId":2026,"briefTitle":2027,"status":795,"phases":2028,"primaryCompletion":2029,"completion":1664,"start":2030,"enrollment":1666,"conditions":2031,"interventions":2033},"NCT01389518","Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome",[92],"2009-07","2009-05",[2032],"Flu",[2015],{"trials":2035,"activeCount":101},[],{"trials":2037,"activeCount":101},[],{"intervention":2039,"totalTrials":97,"cells":2040},"Botulinum toxin type A from laboratory Lanzhou",{"EARLY_PHASE1":2041,"PHASE1":2043,"PHASE2":2045,"PHASE3":2047,"PHASE4":2058,"NA":2060},{"trials":2042,"activeCount":101},[],{"trials":2044,"activeCount":101},[],{"trials":2046,"activeCount":101},[],{"trials":2048,"activeCount":101},[2049],{"nctId":2050,"briefTitle":2051,"status":795,"phases":2052,"primaryCompletion":1926,"completion":2053,"start":531,"enrollment":1185,"conditions":2054,"interventions":2056},"NCT00819065","Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity",[92],"2011-06",[2055],"Spasticity",[2039,2057],"Botulinum toxin type A from laboratory Allergan",{"trials":2059,"activeCount":101},[],{"trials":2061,"activeCount":101},[],{"intervention":2057,"totalTrials":97,"cells":2063},{"EARLY_PHASE1":2064,"PHASE1":2066,"PHASE2":2068,"PHASE3":2070,"PHASE4":2076,"NA":2078},{"trials":2065,"activeCount":101},[],{"trials":2067,"activeCount":101},[],{"trials":2069,"activeCount":101},[],{"trials":2071,"activeCount":101},[2072],{"nctId":2050,"briefTitle":2051,"status":795,"phases":2073,"primaryCompletion":1926,"completion":2053,"start":531,"enrollment":1185,"conditions":2074,"interventions":2075},[92],[2055],[2039,2057],{"trials":2077,"activeCount":101},[],{"trials":2079,"activeCount":101},[],{"intervention":2081,"totalTrials":97,"cells":2082},"Iron Sucrose IV 200mg, once a week, for 5 weeks",{"EARLY_PHASE1":2083,"PHASE1":2085,"PHASE2":2087,"PHASE3":2089,"PHASE4":2101,"NA":2103},{"trials":2084,"activeCount":101},[],{"trials":2086,"activeCount":101},[],{"trials":2088,"activeCount":101},[],{"trials":2090,"activeCount":101},[2091],{"nctId":2092,"briefTitle":2093,"status":529,"phases":2094,"start":2095,"enrollment":2096,"conditions":2097,"interventions":2099},"NCT00386126","Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study",[91,92],"2006-08",117,[21,2098],"Anemia",[2081,2100],"Ferrous sulfate 200mg PO TID, for 8 weeks",{"trials":2102,"activeCount":101},[],{"trials":2104,"activeCount":101},[],{"intervention":2100,"totalTrials":97,"cells":2106},{"EARLY_PHASE1":2107,"PHASE1":2109,"PHASE2":2111,"PHASE3":2113,"PHASE4":2119,"NA":2121},{"trials":2108,"activeCount":101},[],{"trials":2110,"activeCount":101},[],{"trials":2112,"activeCount":101},[],{"trials":2114,"activeCount":101},[2115],{"nctId":2092,"briefTitle":2093,"status":529,"phases":2116,"start":2095,"enrollment":2096,"conditions":2117,"interventions":2118},[91,92],[21,2098],[2081,2100],{"trials":2120,"activeCount":101},[],{"trials":2122,"activeCount":101},[],{"intervention":2124,"totalTrials":97,"cells":2125},"tianeptine",{"EARLY_PHASE1":2126,"PHASE1":2128,"PHASE2":2130,"PHASE3":2132,"PHASE4":2141,"NA":2143},{"trials":2127,"activeCount":101},[],{"trials":2129,"activeCount":101},[],{"trials":2131,"activeCount":101},[],{"trials":2133,"activeCount":101},[2134],{"nctId":2135,"briefTitle":2136,"status":529,"phases":2137,"primaryCompletion":2138,"completion":1111,"start":531,"enrollment":19,"conditions":2139,"interventions":2140},"NCT00879372","Efficacy of Adjunctive Tianeptine in the Treatment of Bipolar Depression",[92],"2013-05",[771],[2124],{"trials":2142,"activeCount":101},[],{"trials":2144,"activeCount":101},[],{"intervention":2146,"totalTrials":97,"cells":2147},"Meropenem",{"EARLY_PHASE1":2148,"PHASE1":2150,"PHASE2":2152,"PHASE3":2154,"PHASE4":2166,"NA":2168},{"trials":2149,"activeCount":101},[],{"trials":2151,"activeCount":101},[],{"trials":2153,"activeCount":101},[],{"trials":2155,"activeCount":101},[2156],{"nctId":2157,"briefTitle":2158,"status":1181,"phases":2159,"primaryCompletion":2160,"completion":2160,"start":2161,"enrollment":19,"conditions":2162,"interventions":2165},"NCT04876430","Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems",[91,92],"2022-03-07","2021-05-04",[2163,2164],"Carbapenem-Resistant Enterobacteriaceae Infection","Bloodstream Infection",[2146],{"trials":2167,"activeCount":101},[],{"trials":2169,"activeCount":101},[],{"intervention":2171,"totalTrials":97,"cells":2172},"Imescard water smartweed composed pills",{"EARLY_PHASE1":2173,"PHASE1":2175,"PHASE2":2177,"PHASE3":2179,"PHASE4":2191,"NA":2193},{"trials":2174,"activeCount":101},[],{"trials":2176,"activeCount":101},[],{"trials":2178,"activeCount":101},[],{"trials":2180,"activeCount":101},[2181],{"nctId":2182,"briefTitle":2183,"status":529,"phases":2184,"primaryCompletion":2185,"completion":2186,"start":1883,"enrollment":1185,"conditions":2187,"interventions":2190},"NCT00861562","Clinical Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed Pills",[92],"2008-10","2009-04",[2188,2189],"Chronic Constipation","Hemorrhoids",[2171],{"trials":2192,"activeCount":101},[],{"trials":2194,"activeCount":101},[],{"intervention":2196,"totalTrials":97,"cells":2197},"Convalescent Plasma",{"EARLY_PHASE1":2198,"PHASE1":2200,"PHASE2":2202,"PHASE3":2204,"PHASE4":2216,"NA":2218},{"trials":2199,"activeCount":101},[],{"trials":2201,"activeCount":101},[],{"trials":2203,"activeCount":101},[],{"trials":2205,"activeCount":101},[2206],{"nctId":2207,"briefTitle":2208,"status":795,"phases":2209,"primaryCompletion":2210,"completion":2210,"start":2211,"enrollment":2212,"conditions":2213,"interventions":2215},"NCT04547660","Convalescent Plasma for Severe COVID-19 Patients",[92],"2021-01-07","2020-07-16",160,[2214],"Covid19",[2196],{"trials":2217,"activeCount":101},[],{"trials":2219,"activeCount":101},[],{"intervention":2221,"totalTrials":97,"cells":2222},"Liraglutide",{"EARLY_PHASE1":2223,"PHASE1":2225,"PHASE2":2227,"PHASE3":2229,"PHASE4":2241,"NA":2243},{"trials":2224,"activeCount":101},[],{"trials":2226,"activeCount":101},[],{"trials":2228,"activeCount":101},[],{"trials":2230,"activeCount":101},[2231],{"nctId":2232,"briefTitle":2233,"status":795,"phases":2234,"primaryCompletion":2235,"completion":2236,"start":2237,"enrollment":9,"conditions":2238,"interventions":2240},"NCT03672812","The Use of Liraglutide in Brain Death",[92],"2019-12-10","2022-02-10","2018-09-01",[2239],"Brain Death",[2221],{"trials":2242,"activeCount":101},[],{"trials":2244,"activeCount":101},[],{"intervention":2246,"totalTrials":97,"cells":2247},"Cannabidiol",{"EARLY_PHASE1":2248,"PHASE1":2250,"PHASE2":2252,"PHASE3":2254,"PHASE4":2268,"NA":2270},{"trials":2249,"activeCount":101},[],{"trials":2251,"activeCount":101},[],{"trials":2253,"activeCount":101},[],{"trials":2255,"activeCount":101},[2256],{"nctId":2257,"briefTitle":2258,"status":1181,"phases":2259,"primaryCompletion":2260,"completion":2261,"start":2262,"enrollment":2263,"conditions":2264,"interventions":2267},"NCT03310593","Cannabidiol as an Adjunctive Treatment for Bipolar Depression",[91,92],"2020-02-24","2020-03-24","2017-11-01",36,[771,2265,2266],"Bipolar Depression","Bipolar Affective Disorder",[2246],{"trials":2269,"activeCount":101},[],{"trials":2271,"activeCount":101},[],{"intervention":2273,"totalTrials":97,"cells":2274},"Testosterone cypionate",{"EARLY_PHASE1":2275,"PHASE1":2277,"PHASE2":2279,"PHASE3":2281,"PHASE4":2294,"NA":2296},{"trials":2276,"activeCount":101},[],{"trials":2278,"activeCount":101},[],{"trials":2280,"activeCount":101},[],{"trials":2282,"activeCount":101},[2283],{"nctId":2284,"briefTitle":2285,"status":529,"phases":2286,"primaryCompletion":2287,"completion":2288,"start":2289,"enrollment":2290,"conditions":2291,"interventions":2293},"NCT03038919","Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness",[91,92],"2017-10","2018-01","2016-10",30,[2292],"Critical Illness Polyneuropathies",[2273],{"trials":2295,"activeCount":101},[],{"trials":2297,"activeCount":101},[],{"intervention":2299,"totalTrials":97,"cells":2300},"Sulpiride use",{"EARLY_PHASE1":2301,"PHASE1":2303,"PHASE2":2305,"PHASE3":2307,"PHASE4":2319,"NA":2321},{"trials":2302,"activeCount":101},[],{"trials":2304,"activeCount":101},[],{"trials":2306,"activeCount":101},[],{"trials":2308,"activeCount":101},[2309],{"nctId":2310,"briefTitle":2311,"status":795,"phases":2312,"primaryCompletion":2287,"completion":2313,"start":2314,"enrollment":11,"conditions":2315,"interventions":2318},"NCT02749747","Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric",[92],"2017-12","2014-06",[2316,2317],"Menopausal Syndrome","Hot Flashes",[2299],{"trials":2320,"activeCount":101},[],{"trials":2322,"activeCount":101},[],{"intervention":2324,"totalTrials":97,"cells":2325},"Lithium Carbonate",{"EARLY_PHASE1":2326,"PHASE1":2328,"PHASE2":2330,"PHASE3":2332,"PHASE4":2346,"NA":2348},{"trials":2327,"activeCount":101},[],{"trials":2329,"activeCount":101},[],{"trials":2331,"activeCount":101},[],{"trials":2333,"activeCount":101},[2334],{"nctId":2335,"briefTitle":2336,"status":795,"phases":2337,"primaryCompletion":2338,"completion":2339,"start":2340,"enrollment":2341,"conditions":2342,"interventions":2345},"NCT01096082","Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3",[91,92],"2012-12","2013-01","2011-05",62,[2343,2344],"Spinocerebellar Ataxia Type 3","Machado Joseph Disease",[2324],{"trials":2347,"activeCount":101},[],{"trials":2349,"activeCount":101},[],{"intervention":2351,"totalTrials":97,"cells":2352},"Testosterone",{"EARLY_PHASE1":2353,"PHASE1":2355,"PHASE2":2357,"PHASE3":2359,"PHASE4":2372,"NA":2374},{"trials":2354,"activeCount":101},[],{"trials":2356,"activeCount":101},[],{"trials":2358,"activeCount":101},[],{"trials":2360,"activeCount":101},[2361],{"nctId":2362,"briefTitle":2363,"status":529,"phases":2364,"primaryCompletion":2288,"completion":2365,"start":2366,"enrollment":2367,"conditions":2368,"interventions":2370},"NCT03238092","Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort",[92],"2018-03","2017-08",26,[2369],"Fertility Disorders",[2351,2371],"Estradiol",{"trials":2373,"activeCount":101},[],{"trials":2375,"activeCount":101},[],{"intervention":2377,"totalTrials":97,"cells":2378},"clomiphene citrate",{"EARLY_PHASE1":2379,"PHASE1":2381,"PHASE2":2383,"PHASE3":2385,"PHASE4":2395,"NA":2397},{"trials":2380,"activeCount":101},[],{"trials":2382,"activeCount":101},[],{"trials":2384,"activeCount":101},[],{"trials":2386,"activeCount":101},[2387],{"nctId":2388,"briefTitle":2389,"status":795,"phases":2390,"primaryCompletion":532,"completion":532,"start":533,"enrollment":2391,"conditions":2392,"interventions":2393},"NCT00427700","Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome",[92],82,[1021],[2377,2394],"raloxifene",{"trials":2396,"activeCount":101},[],{"trials":2398,"activeCount":101},[],{"intervention":2394,"totalTrials":97,"cells":2400},{"EARLY_PHASE1":2401,"PHASE1":2403,"PHASE2":2405,"PHASE3":2407,"PHASE4":2413,"NA":2415},{"trials":2402,"activeCount":101},[],{"trials":2404,"activeCount":101},[],{"trials":2406,"activeCount":101},[],{"trials":2408,"activeCount":101},[2409],{"nctId":2388,"briefTitle":2389,"status":795,"phases":2410,"primaryCompletion":532,"completion":532,"start":533,"enrollment":2391,"conditions":2411,"interventions":2412},[92],[1021],[2377,2394],{"trials":2414,"activeCount":101},[],{"trials":2416,"activeCount":101},[],{"intervention":2418,"totalTrials":97,"cells":2419},"Cyproheptadine",{"EARLY_PHASE1":2420,"PHASE1":2422,"PHASE2":2424,"PHASE3":2426,"PHASE4":2439,"NA":2441},{"trials":2421,"activeCount":101},[],{"trials":2423,"activeCount":101},[],{"trials":2425,"activeCount":101},[],{"trials":2427,"activeCount":101},[2428],{"nctId":2429,"briefTitle":2430,"status":529,"phases":2431,"primaryCompletion":2432,"completion":2433,"start":2434,"enrollment":2435,"conditions":2436,"interventions":2438},"NCT04979221","Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19",[92],"2022-01-26","2022-02-28","2021-07-26",274,[2437],"COVID-19 Pneumonia",[2418],{"trials":2440,"activeCount":101},[],{"trials":2442,"activeCount":101},[],{"intervention":2444,"totalTrials":97,"cells":2445},"Imescard compound water smartweed ointment",{"EARLY_PHASE1":2446,"PHASE1":2448,"PHASE2":2450,"PHASE3":2452,"PHASE4":2461,"NA":2463},{"trials":2447,"activeCount":101},[],{"trials":2449,"activeCount":101},[],{"trials":2451,"activeCount":101},[],{"trials":2453,"activeCount":101},[2454],{"nctId":2455,"briefTitle":2456,"status":529,"phases":2457,"primaryCompletion":2030,"start":1883,"enrollment":729,"conditions":2458,"interventions":2460},"NCT00935948","Efficacy and Safety Evaluation of the Imescard Compound Water Smartweed Ointment",[92],[2459],"Hemorrhoidal Disease",[2444],{"trials":2462,"activeCount":101},[],{"trials":2464,"activeCount":101},[],{"intervention":1670,"totalTrials":97,"cells":2466},{"EARLY_PHASE1":2467,"PHASE1":2469,"PHASE2":2471,"PHASE3":2473,"PHASE4":2479,"NA":2481},{"trials":2468,"activeCount":101},[],{"trials":2470,"activeCount":101},[],{"trials":2472,"activeCount":101},[],{"trials":2474,"activeCount":101},[2475],{"nctId":1661,"briefTitle":1662,"status":529,"phases":2476,"primaryCompletion":1664,"start":1665,"enrollment":1666,"conditions":2477,"interventions":2478},[92],[1657,1668],[1639,1670],{"trials":2480,"activeCount":101},[],{"trials":2482,"activeCount":101},[],{"intervention":2484,"totalTrials":97,"cells":2485},"Melatonin and Placebo",{"EARLY_PHASE1":2486,"PHASE1":2488,"PHASE2":2490,"PHASE3":2492,"PHASE4":2505,"NA":2507},{"trials":2487,"activeCount":101},[],{"trials":2489,"activeCount":101},[],{"trials":2491,"activeCount":101},[],{"trials":2493,"activeCount":101},[2494],{"nctId":2495,"briefTitle":2496,"status":529,"phases":2497,"primaryCompletion":1044,"completion":2498,"start":2499,"enrollment":2500,"conditions":2501,"interventions":2502},"NCT02041455","Immune-Pineal Axis Function in Fibromyalgia",[91,92],"2014-03","2010-06",66,[18],[2484,2503,2504],"Amitriptyline and Placebo","Melatonin and Amitriptylin",{"trials":2506,"activeCount":101},[],{"trials":2508,"activeCount":101},[],{"intervention":2503,"totalTrials":97,"cells":2510},{"EARLY_PHASE1":2511,"PHASE1":2513,"PHASE2":2515,"PHASE3":2517,"PHASE4":2523,"NA":2525},{"trials":2512,"activeCount":101},[],{"trials":2514,"activeCount":101},[],{"trials":2516,"activeCount":101},[],{"trials":2518,"activeCount":101},[2519],{"nctId":2495,"briefTitle":2496,"status":529,"phases":2520,"primaryCompletion":1044,"completion":2498,"start":2499,"enrollment":2500,"conditions":2521,"interventions":2522},[91,92],[18],[2484,2503,2504],{"trials":2524,"activeCount":101},[],{"trials":2526,"activeCount":101},[],{"intervention":2504,"totalTrials":97,"cells":2528},{"EARLY_PHASE1":2529,"PHASE1":2531,"PHASE2":2533,"PHASE3":2535,"PHASE4":2541,"NA":2543},{"trials":2530,"activeCount":101},[],{"trials":2532,"activeCount":101},[],{"trials":2534,"activeCount":101},[],{"trials":2536,"activeCount":101},[2537],{"nctId":2495,"briefTitle":2496,"status":529,"phases":2538,"primaryCompletion":1044,"completion":2498,"start":2499,"enrollment":2500,"conditions":2539,"interventions":2540},[91,92],[18],[2484,2503,2504],{"trials":2542,"activeCount":101},[],{"trials":2544,"activeCount":101},[],{"intervention":2546,"totalTrials":97,"cells":2547},"Melatonin Pill",{"EARLY_PHASE1":2548,"PHASE1":2550,"PHASE2":2552,"PHASE3":2567,"PHASE4":2569,"NA":2571},{"trials":2549,"activeCount":101},[],{"trials":2551,"activeCount":101},[],{"trials":2553,"activeCount":101},[2554],{"nctId":2555,"briefTitle":2556,"status":1181,"phases":2557,"primaryCompletion":2558,"completion":2559,"start":2560,"enrollment":2561,"conditions":2562,"interventions":2566},"NCT03725267","Melatonin for Renal Protection in Patients Receiving Polymyxin B",[91],"2021-06-15","2021-07-01","2018-10-01",88,[2563,2564,2565],"Acute Kidney Injury","Melatonin","Polymyxin B Adverse Reaction",[2546],{"trials":2568,"activeCount":101},[],{"trials":2570,"activeCount":101},[],{"trials":2572,"activeCount":101},[],{"intervention":2574,"totalTrials":97,"cells":2575},"Amiloride 2,5\u002Fd or Enalapril\u002Fd 10 mg",{"EARLY_PHASE1":2576,"PHASE1":2578,"PHASE2":2580,"PHASE3":2589,"PHASE4":2591,"NA":2593},{"trials":2577,"activeCount":101},[],{"trials":2579,"activeCount":101},[],{"trials":2581,"activeCount":101},[2582],{"nctId":2583,"briefTitle":2584,"status":795,"phases":2585,"start":2586,"conditions":2587,"interventions":2588},"NCT00394394","Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril",[91],"2005-02",[15],[2574],{"trials":2590,"activeCount":101},[],{"trials":2592,"activeCount":101},[],{"trials":2594,"activeCount":101},[],{"intervention":2564,"totalTrials":97,"cells":2596},{"EARLY_PHASE1":2597,"PHASE1":2599,"PHASE2":2601,"PHASE3":2611,"PHASE4":2613,"NA":2615},{"trials":2598,"activeCount":101},[],{"trials":2600,"activeCount":101},[],{"trials":2602,"activeCount":101},[2603],{"nctId":2604,"briefTitle":2605,"status":529,"phases":2606,"primaryCompletion":2607,"completion":2607,"start":2498,"enrollment":9,"conditions":2608,"interventions":2610},"NCT02195271","Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects.",[91],"2014-08",[2609,29],"Analgesia Disorder",[2564],{"trials":2612,"activeCount":101},[],{"trials":2614,"activeCount":101},[],{"trials":2616,"activeCount":101},[],{"intervention":2618,"totalTrials":97,"cells":2619},"Conjugated Equine Estrogen",{"EARLY_PHASE1":2620,"PHASE1":2622,"PHASE2":2624,"PHASE3":2636,"PHASE4":2638,"NA":2640},{"trials":2621,"activeCount":101},[],{"trials":2623,"activeCount":101},[],{"trials":2625,"activeCount":101},[2626],{"nctId":2627,"briefTitle":2628,"status":529,"phases":2629,"primaryCompletion":2630,"completion":1234,"start":2631,"enrollment":2632,"conditions":2633,"interventions":2635},"NCT02838576","Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women",[91],"2019-12-02","2017-03-01",72,[2634],"Arthralgia",[2618],{"trials":2637,"activeCount":101},[],{"trials":2639,"activeCount":101},[],{"trials":2641,"activeCount":101},[],{"intervention":2643,"totalTrials":97,"cells":2644},"mesenchymal stem cells",{"EARLY_PHASE1":2645,"PHASE1":2647,"PHASE2":2649,"PHASE3":2661,"PHASE4":2663,"NA":2665},{"trials":2646,"activeCount":101},[],{"trials":2648,"activeCount":101},[],{"trials":2650,"activeCount":101},[2651],{"nctId":2652,"briefTitle":2653,"status":529,"phases":2654,"primaryCompletion":2655,"completion":911,"start":2656,"enrollment":284,"conditions":2657,"interventions":2659},"NCT02770430","Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease",[91],"2017-09","2015-09",[2658],"Graft vs Host Disease",[2643,2660],"conventional treatment",{"trials":2662,"activeCount":101},[],{"trials":2664,"activeCount":101},[],{"trials":2666,"activeCount":101},[],{"intervention":2668,"totalTrials":97,"cells":2669},"Recombinant tissue plasminogen activator",{"EARLY_PHASE1":2670,"PHASE1":2672,"PHASE2":2674,"PHASE3":2684,"PHASE4":2686,"NA":2688},{"trials":2671,"activeCount":101},[],{"trials":2673,"activeCount":101},[],{"trials":2675,"activeCount":101},[2676],{"nctId":2677,"briefTitle":2678,"status":2679,"phases":2680,"primaryCompletion":2656,"completion":2656,"start":1926,"enrollment":101,"conditions":2681,"interventions":2683},"NCT01133223","Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke","WITHDRAWN",[91],[2682],"Stroke",[2668],{"trials":2685,"activeCount":101},[],{"trials":2687,"activeCount":101},[],{"trials":2689,"activeCount":101},[],{"intervention":2691,"totalTrials":97,"cells":2692},"amido pill",{"EARLY_PHASE1":2693,"PHASE1":2695,"PHASE2":2697,"PHASE3":2709,"PHASE4":2711,"NA":2713},{"trials":2694,"activeCount":101},[],{"trials":2696,"activeCount":101},[],{"trials":2698,"activeCount":101},[2699],{"nctId":2700,"briefTitle":2701,"status":529,"phases":2702,"primaryCompletion":2703,"completion":2703,"start":2704,"enrollment":995,"conditions":2705,"interventions":2707},"NCT00452608","Statin for Immunomudulation in Sepsis",[91],"2009-12","2006-12",[2706],"Sepsis",[2691,2708],"atorvastatina",{"trials":2710,"activeCount":101},[],{"trials":2712,"activeCount":101},[],{"trials":2714,"activeCount":101},[],{"intervention":2708,"totalTrials":97,"cells":2716},{"EARLY_PHASE1":2717,"PHASE1":2719,"PHASE2":2721,"PHASE3":2727,"PHASE4":2729,"NA":2731},{"trials":2718,"activeCount":101},[],{"trials":2720,"activeCount":101},[],{"trials":2722,"activeCount":101},[2723],{"nctId":2700,"briefTitle":2701,"status":529,"phases":2724,"primaryCompletion":2703,"completion":2703,"start":2704,"enrollment":995,"conditions":2725,"interventions":2726},[91],[2706],[2691,2708],{"trials":2728,"activeCount":101},[],{"trials":2730,"activeCount":101},[],{"trials":2732,"activeCount":101},[],{"intervention":2734,"totalTrials":97,"cells":2735},"Chronic Myeloid Leukemia + NK cell",{"EARLY_PHASE1":2736,"PHASE1":2738,"PHASE2":2740,"PHASE3":2752,"PHASE4":2754,"NA":2756},{"trials":2737,"activeCount":101},[],{"trials":2739,"activeCount":101},[],{"trials":2741,"activeCount":101},[2742],{"nctId":2743,"briefTitle":2744,"status":529,"phases":2745,"primaryCompletion":727,"completion":2746,"start":2747,"enrollment":2748,"conditions":2749,"interventions":2751},"NCT03348033","Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia",[90,91],"2023-03","2019-03",5,[2750],"Chronic Myeloid Leukemia",[2734],{"trials":2753,"activeCount":101},[],{"trials":2755,"activeCount":101},[],{"trials":2757,"activeCount":101},[],{"intervention":2759,"totalTrials":97,"cells":2760},"Sodium Phenylbutyrate",{"EARLY_PHASE1":2761,"PHASE1":2763,"PHASE2":2765,"PHASE3":2774,"PHASE4":2776,"NA":2778},{"trials":2762,"activeCount":101},[],{"trials":2764,"activeCount":101},[],{"trials":2766,"activeCount":101},[2767],{"nctId":2768,"briefTitle":2769,"status":2679,"phases":2770,"primaryCompletion":1112,"completion":2771,"start":2499,"enrollment":101,"conditions":2772,"interventions":2773},"NCT01096095","Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3",[91],"2011-07",[2343],[2759],{"trials":2775,"activeCount":101},[],{"trials":2777,"activeCount":101},[],{"trials":2779,"activeCount":101},[],{"intervention":2781,"totalTrials":97,"cells":2782},"a-tDCS and nutritional counseling",{"EARLY_PHASE1":2783,"PHASE1":2785,"PHASE2":2787,"PHASE3":2801,"PHASE4":2803,"NA":2805},{"trials":2784,"activeCount":101},[],{"trials":2786,"activeCount":101},[],{"trials":2788,"activeCount":101},[2789],{"nctId":2790,"briefTitle":2791,"status":529,"phases":2792,"primaryCompletion":2793,"completion":1499,"start":2794,"enrollment":1747,"conditions":2795,"interventions":2799},"NCT04226794","Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction",[91],"2021-12-21","2019-06-10",[2796,2797,2798],"Transcranial Direct Current Stimulation","Binge-Eating Disorder","Cognitive Behavioral Therapy",[2781,2800],"s-tDCS and nutritional counseling",{"trials":2802,"activeCount":101},[],{"trials":2804,"activeCount":101},[],{"trials":2806,"activeCount":101},[],{"intervention":2800,"totalTrials":97,"cells":2808},{"EARLY_PHASE1":2809,"PHASE1":2811,"PHASE2":2813,"PHASE3":2819,"PHASE4":2821,"NA":2823},{"trials":2810,"activeCount":101},[],{"trials":2812,"activeCount":101},[],{"trials":2814,"activeCount":101},[2815],{"nctId":2790,"briefTitle":2791,"status":529,"phases":2816,"primaryCompletion":2793,"completion":1499,"start":2794,"enrollment":1747,"conditions":2817,"interventions":2818},[91],[2796,2797,2798],[2781,2800],{"trials":2820,"activeCount":101},[],{"trials":2822,"activeCount":101},[],{"trials":2824,"activeCount":101},[],{"intervention":2826,"totalTrials":97,"cells":2827},"Remifentanil",{"EARLY_PHASE1":2828,"PHASE1":2830,"PHASE2":2832,"PHASE3":2842,"PHASE4":2844,"NA":2846},{"trials":2829,"activeCount":101},[],{"trials":2831,"activeCount":101},[],{"trials":2833,"activeCount":101},[2834],{"nctId":2835,"briefTitle":2836,"status":529,"phases":2837,"primaryCompletion":1770,"completion":728,"start":866,"enrollment":2838,"conditions":2839,"interventions":2841},"NCT02432677","Evaluation of the Potentiating Effect of tDCS on Opioid Analgesia of Pain Threshold in Humans",[91],48,[2840],"Acute Pain",[2826],{"trials":2843,"activeCount":101},[],{"trials":2845,"activeCount":101},[],{"trials":2847,"activeCount":101},[],{"intervention":2849,"totalTrials":97,"cells":2850},"Acetaminophen",{"EARLY_PHASE1":2851,"PHASE1":2853,"PHASE2":2855,"PHASE3":2869,"PHASE4":2871,"NA":2873},{"trials":2852,"activeCount":101},[],{"trials":2854,"activeCount":101},[],{"trials":2856,"activeCount":101},[2857],{"nctId":2858,"briefTitle":2859,"status":2860,"phases":2861,"primaryCompletion":2862,"completion":2863,"start":2864,"enrollment":1615,"conditions":2865,"interventions":2867},"NCT04015557","Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria","SUSPENDED",[90,91],"2022-06-30","2022-12-01","2022-02-11",[2866],"CBS Deficiency",[2849,2868],"N-acetylcysteine",{"trials":2870,"activeCount":101},[],{"trials":2872,"activeCount":101},[],{"trials":2874,"activeCount":101},[],{"intervention":2868,"totalTrials":97,"cells":2876},{"EARLY_PHASE1":2877,"PHASE1":2879,"PHASE2":2881,"PHASE3":2887,"PHASE4":2889,"NA":2891},{"trials":2878,"activeCount":101},[],{"trials":2880,"activeCount":101},[],{"trials":2882,"activeCount":101},[2883],{"nctId":2858,"briefTitle":2859,"status":2860,"phases":2884,"primaryCompletion":2862,"completion":2863,"start":2864,"enrollment":1615,"conditions":2885,"interventions":2886},[90,91],[2866],[2849,2868],{"trials":2888,"activeCount":101},[],{"trials":2890,"activeCount":101},[],{"trials":2892,"activeCount":101},[],{"intervention":2894,"totalTrials":97,"cells":2895},"Albumin",{"EARLY_PHASE1":2896,"PHASE1":2898,"PHASE2":2900,"PHASE3":2913,"PHASE4":2915,"NA":2917},{"trials":2897,"activeCount":101},[],{"trials":2899,"activeCount":101},[],{"trials":2901,"activeCount":101},[2902],{"nctId":2903,"briefTitle":2904,"status":529,"phases":2905,"primaryCompletion":532,"completion":2906,"start":2907,"enrollment":2908,"conditions":2909,"interventions":2912},"NCT00852800","Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study",[91],"2011-03","2006-03",43,[2910,2911],"Renal Impairment","All Cause Mortality",[2894,2894],{"trials":2914,"activeCount":101},[],{"trials":2916,"activeCount":101},[],{"trials":2918,"activeCount":101},[],{"intervention":2920,"totalTrials":97,"cells":2921},"NK Cells + Chemotherapy Starting",{"EARLY_PHASE1":2922,"PHASE1":2924,"PHASE2":2926,"PHASE3":2938,"PHASE4":2940,"NA":2942},{"trials":2923,"activeCount":101},[],{"trials":2925,"activeCount":101},[],{"trials":2927,"activeCount":101},[2928],{"nctId":2929,"briefTitle":2930,"status":529,"phases":2931,"primaryCompletion":2932,"completion":2933,"start":2934,"enrollment":2290,"conditions":2935,"interventions":2937},"NCT02809092","Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia",[90,91],"2019-09-30","2020-09","2017-04-01",[2936],"Acute Myeloid Leukemia",[2920],{"trials":2939,"activeCount":101},[],{"trials":2941,"activeCount":101},[],{"trials":2943,"activeCount":101},[],{"intervention":2945,"totalTrials":97,"cells":2946},"Sildenafil Citrate, 25 mg, 3 times a day.",{"EARLY_PHASE1":2947,"PHASE1":2949,"PHASE2":2951,"PHASE3":2963,"PHASE4":2965,"NA":2967},{"trials":2948,"activeCount":101},[],{"trials":2950,"activeCount":101},[],{"trials":2952,"activeCount":101},[2953],{"nctId":2954,"briefTitle":2955,"status":2679,"phases":2956,"primaryCompletion":2338,"start":1283,"enrollment":101,"conditions":2957,"interventions":2961},"NCT01091870","Sildenafil for Prevention of Cerebral Vasospasm",[91],[2958,2959,2960],"Subarachnoid Hemorrhage","Cerebral Vasospasm","Rupture of Intracranial Aneurysm",[2945,2962],"Sildenafil Citrate 50 mg, 3 times a day",{"trials":2964,"activeCount":101},[],{"trials":2966,"activeCount":101},[],{"trials":2968,"activeCount":101},[],{"intervention":2962,"totalTrials":97,"cells":2970},{"EARLY_PHASE1":2971,"PHASE1":2973,"PHASE2":2975,"PHASE3":2981,"PHASE4":2983,"NA":2985},{"trials":2972,"activeCount":101},[],{"trials":2974,"activeCount":101},[],{"trials":2976,"activeCount":101},[2977],{"nctId":2954,"briefTitle":2955,"status":2679,"phases":2978,"primaryCompletion":2338,"start":1283,"enrollment":101,"conditions":2979,"interventions":2980},[91],[2958,2959,2960],[2945,2962],{"trials":2982,"activeCount":101},[],{"trials":2984,"activeCount":101},[],{"trials":2986,"activeCount":101},[],{"intervention":2988,"totalTrials":97,"cells":2989},"Melatonin 20 MG Oral",{"EARLY_PHASE1":2990,"PHASE1":2992,"PHASE2":2994,"PHASE3":3006,"PHASE4":3008,"NA":3010},{"trials":2991,"activeCount":101},[],{"trials":2993,"activeCount":101},[],{"trials":2995,"activeCount":101},[2996],{"nctId":2997,"briefTitle":2998,"status":795,"phases":2999,"primaryCompletion":912,"completion":912,"start":3000,"enrollment":2263,"conditions":3001,"interventions":3005},"NCT03205033","Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy",[91],"2016-01",[3002,3003,3004,29],"Sleep Disorders, Circadian Rhythm","Depression","Genotoxicity",[2988],{"trials":3007,"activeCount":101},[],{"trials":3009,"activeCount":101},[],{"trials":3011,"activeCount":101},[],{"intervention":3013,"totalTrials":97,"cells":3014},"Vehicle Gel Base",{"EARLY_PHASE1":3015,"PHASE1":3017,"PHASE2":3035,"PHASE3":3037,"PHASE4":3039,"NA":3041},{"trials":3016,"activeCount":101},[],{"trials":3018,"activeCount":101},[3019],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3022,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3027,"interventions":3029},"NCT04219358","Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis",[90],"2020-06-24","2021-08-24","2019-03-23",49,[3028],"Actinic Cheilitis",[3013,3030,3031,3032,3033,3034],"Imiquimod 5% gel","Imiquimod 0,05% gel","Imiquimod nanoencapsulated 0,05% gel","Lip sunscreen 30 Sun Protector Factor","Dexpanthenol",{"trials":3036,"activeCount":101},[],{"trials":3038,"activeCount":101},[],{"trials":3040,"activeCount":101},[],{"trials":3042,"activeCount":101},[],{"intervention":3030,"totalTrials":97,"cells":3044},{"EARLY_PHASE1":3045,"PHASE1":3047,"PHASE2":3053,"PHASE3":3055,"PHASE4":3057,"NA":3059},{"trials":3046,"activeCount":101},[],{"trials":3048,"activeCount":101},[3049],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3050,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3051,"interventions":3052},[90],[3028],[3013,3030,3031,3032,3033,3034],{"trials":3054,"activeCount":101},[],{"trials":3056,"activeCount":101},[],{"trials":3058,"activeCount":101},[],{"trials":3060,"activeCount":101},[],{"intervention":3031,"totalTrials":97,"cells":3062},{"EARLY_PHASE1":3063,"PHASE1":3065,"PHASE2":3071,"PHASE3":3073,"PHASE4":3075,"NA":3077},{"trials":3064,"activeCount":101},[],{"trials":3066,"activeCount":101},[3067],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3068,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3069,"interventions":3070},[90],[3028],[3013,3030,3031,3032,3033,3034],{"trials":3072,"activeCount":101},[],{"trials":3074,"activeCount":101},[],{"trials":3076,"activeCount":101},[],{"trials":3078,"activeCount":101},[],{"intervention":3032,"totalTrials":97,"cells":3080},{"EARLY_PHASE1":3081,"PHASE1":3083,"PHASE2":3089,"PHASE3":3091,"PHASE4":3093,"NA":3095},{"trials":3082,"activeCount":101},[],{"trials":3084,"activeCount":101},[3085],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3086,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3087,"interventions":3088},[90],[3028],[3013,3030,3031,3032,3033,3034],{"trials":3090,"activeCount":101},[],{"trials":3092,"activeCount":101},[],{"trials":3094,"activeCount":101},[],{"trials":3096,"activeCount":101},[],{"intervention":3033,"totalTrials":97,"cells":3098},{"EARLY_PHASE1":3099,"PHASE1":3101,"PHASE2":3107,"PHASE3":3109,"PHASE4":3111,"NA":3113},{"trials":3100,"activeCount":101},[],{"trials":3102,"activeCount":101},[3103],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3104,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3105,"interventions":3106},[90],[3028],[3013,3030,3031,3032,3033,3034],{"trials":3108,"activeCount":101},[],{"trials":3110,"activeCount":101},[],{"trials":3112,"activeCount":101},[],{"trials":3114,"activeCount":101},[],{"intervention":3034,"totalTrials":97,"cells":3116},{"EARLY_PHASE1":3117,"PHASE1":3119,"PHASE2":3125,"PHASE3":3127,"PHASE4":3129,"NA":3131},{"trials":3118,"activeCount":101},[],{"trials":3120,"activeCount":101},[3121],{"nctId":3020,"briefTitle":3021,"status":1181,"phases":3122,"primaryCompletion":3023,"completion":3024,"start":3025,"enrollment":3026,"conditions":3123,"interventions":3124},[90],[3028],[3013,3030,3031,3032,3033,3034],{"trials":3126,"activeCount":101},[],{"trials":3128,"activeCount":101},[],{"trials":3130,"activeCount":101},[],{"trials":3132,"activeCount":101},[],{"intervention":3134,"totalTrials":97,"cells":3135},"Mesenchymal Stromal Cells",{"EARLY_PHASE1":3136,"PHASE1":3138,"PHASE2":3151,"PHASE3":3153,"PHASE4":3155,"NA":3157},{"trials":3137,"activeCount":101},[],{"trials":3139,"activeCount":101},[3140],{"nctId":3141,"briefTitle":3142,"status":529,"phases":3143,"primaryCompletion":3144,"completion":3145,"start":3146,"enrollment":1615,"conditions":3147,"interventions":3150},"NCT04467047","Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19",[90],"2020-10-30","2020-12-30","2020-07-25",[3148,3149],"COVID-19","Sars-CoV2",[3134],{"trials":3152,"activeCount":101},[],{"trials":3154,"activeCount":101},[],{"trials":3156,"activeCount":101},[],{"trials":3158,"activeCount":101},[],{"intervention":3160,"totalTrials":97,"cells":3161},"Natural Killer Cells",{"EARLY_PHASE1":3162,"PHASE1":3164,"PHASE2":3175,"PHASE3":3177,"PHASE4":3179,"NA":3181},{"trials":3163,"activeCount":101},[],{"trials":3165,"activeCount":101},[3166],{"nctId":3167,"briefTitle":3168,"status":529,"phases":3169,"primaryCompletion":3170,"completion":3170,"start":3171,"enrollment":16,"conditions":3172,"interventions":3174},"NCT04634370","Fase I Clinical Trial on NK Cells for COVID-19",[90],"2021-03-30","2021-01-02",[2214,3173],"Sars-cov 2",[3160],{"trials":3176,"activeCount":101},[],{"trials":3178,"activeCount":101},[],{"trials":3180,"activeCount":101},[],{"trials":3182,"activeCount":101},[],{"intervention":3184,"totalTrials":97,"cells":3185},"Eggplant extract",{"EARLY_PHASE1":3186,"PHASE1":3188,"PHASE2":3200,"PHASE3":3202,"PHASE4":3204,"NA":3206},{"trials":3187,"activeCount":101},[],{"trials":3189,"activeCount":101},[3190],{"nctId":3191,"briefTitle":3192,"status":795,"phases":3193,"primaryCompletion":3194,"completion":1309,"start":3195,"enrollment":3196,"conditions":3197,"interventions":3199},"NCT00845637","Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period",[90],"2007-03","2004-03",59,[3198],"Dyslipidemia",[3184],{"trials":3201,"activeCount":101},[],{"trials":3203,"activeCount":101},[],{"trials":3205,"activeCount":101},[],{"trials":3207,"activeCount":101},[],{"intervention":3209,"totalTrials":97,"cells":3210},"Domperidone",{"EARLY_PHASE1":3211,"PHASE1":3220,"PHASE2":3222,"PHASE3":3224,"PHASE4":3226,"NA":3228},{"trials":3212,"activeCount":101},[3213],{"nctId":3214,"briefTitle":3215,"status":795,"phases":3216,"primaryCompletion":1770,"completion":1812,"start":1688,"enrollment":2290,"conditions":3217,"interventions":3219},"NCT03221855","Use of Domperidone to Increase Milk Production in Mothers With Newborns in Neonatology",[89],[3218],"Breastfeeding",[3209],{"trials":3221,"activeCount":101},[],{"trials":3223,"activeCount":101},[],{"trials":3225,"activeCount":101},[],{"trials":3227,"activeCount":101},[],{"trials":3229,"activeCount":101},[],{"intervention":3231,"totalTrials":1556,"cells":3232},"Ketamine",{"EARLY_PHASE1":3233,"PHASE1":3235,"PHASE2":3237,"PHASE3":3239,"PHASE4":3260,"NA":3262},{"trials":3234,"activeCount":101},[],{"trials":3236,"activeCount":101},[],{"trials":3238,"activeCount":101},[],{"trials":3240,"activeCount":101},[3241,3251],{"nctId":3242,"briefTitle":3243,"status":795,"phases":3244,"primaryCompletion":2289,"completion":2289,"start":3245,"enrollment":3246,"conditions":3247,"interventions":3250},"NCT02929524","Intranasal Ketamine as a Sedative for Venipuncture",[91,92],"2015-04",39,[3248,2840,3249],"Respiratory Tract Disease","Diseases of the Digestive System",[3231],{"nctId":3252,"briefTitle":3253,"status":795,"phases":3254,"primaryCompletion":3255,"completion":3255,"start":3256,"enrollment":16,"conditions":3257,"interventions":3259},"NCT03915938","Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain",[91,92],"2017-11-30","2017-01-02",[2840,3258,1313],"Chronic Pain, Widespread",[3231],{"trials":3261,"activeCount":101},[],{"trials":3263,"activeCount":101},[3264],{"nctId":3265,"briefTitle":3266,"status":529,"phases":3267,"primaryCompletion":3268,"completion":3269,"start":3270,"enrollment":284,"conditions":3271,"interventions":3276},"NCT05249309","Naturalistic Study of Ketamine in the Treatment of Depression",[],"2022-11-01","2023-12-15","2021-05-01",[3272,771,2265,3273,3274,3275],"Major Depressive Disorder","Bipolar I Disorder","Bipolar II Disorder","Affective Disorder",[3231],{"intervention":1526,"totalTrials":1556,"cells":3278},{"EARLY_PHASE1":3279,"PHASE1":3281,"PHASE2":3283,"PHASE3":3285,"PHASE4":3287,"NA":3299},{"trials":3280,"activeCount":101},[],{"trials":3282,"activeCount":101},[],{"trials":3284,"activeCount":101},[],{"trials":3286,"activeCount":101},[],{"trials":3288,"activeCount":101},[3289,3295],{"nctId":3290,"briefTitle":3291,"status":529,"phases":3292,"primaryCompletion":1136,"completion":1770,"start":2138,"enrollment":1089,"conditions":3293,"interventions":3294},"NCT02072382","The Hypotensive Effect of Metformin in Hypertensive Patients.",[93],[15],[1526],{"nctId":1520,"briefTitle":1521,"status":529,"phases":3296,"primaryCompletion":1043,"completion":1335,"start":1044,"enrollment":995,"conditions":3297,"interventions":3298},[93],[1524],[1526,1507],{"trials":3300,"activeCount":101},[3301],{"nctId":3302,"briefTitle":3303,"status":529,"phases":3304,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":3309,"interventions":3311},"NCT00935805","Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy",[],"2012-01","2012-07","2006-07",124,[1211,3310],"Arterial Hypertension",[1526,3312,3313,3314,3315,3316,1587],"Glybenclamide","NPH insulin","Hydrochlorothiazide","Propranolol","Captopril",{"intervention":2371,"totalTrials":508,"cells":3318},{"EARLY_PHASE1":3319,"PHASE1":3321,"PHASE2":3323,"PHASE3":3325,"PHASE4":3331,"NA":3333},{"trials":3320,"activeCount":101},[],{"trials":3322,"activeCount":101},[],{"trials":3324,"activeCount":101},[],{"trials":3326,"activeCount":101},[3327],{"nctId":2362,"briefTitle":2363,"status":529,"phases":3328,"primaryCompletion":2288,"completion":2365,"start":2366,"enrollment":2367,"conditions":3329,"interventions":3330},[92],[2369],[2351,2371],{"trials":3332,"activeCount":101},[],{"trials":3334,"activeCount":101},[3335],{"nctId":3336,"briefTitle":3337,"status":529,"phases":3338,"primaryCompletion":3339,"completion":3339,"start":3340,"enrollment":2290,"conditions":3341,"interventions":3343},"NCT03651427","Cross-sex Hormone Therapy and Neuronal Plasticity",[94],"2019-03-30","2017-02-13",[3342],"Gender Dysphoria",[2371],{"intervention":1587,"totalTrials":508,"cells":3345},{"EARLY_PHASE1":3346,"PHASE1":3348,"PHASE2":3350,"PHASE3":3352,"PHASE4":3358,"NA":3360},{"trials":3347,"activeCount":101},[],{"trials":3349,"activeCount":101},[],{"trials":3351,"activeCount":101},[],{"trials":3353,"activeCount":101},[3354],{"nctId":1577,"briefTitle":1578,"status":795,"phases":3355,"primaryCompletion":1580,"completion":1581,"start":1582,"enrollment":1583,"conditions":3356,"interventions":3357},[92],[15,1585],[1555,1587],{"trials":3359,"activeCount":101},[],{"trials":3361,"activeCount":101},[3362],{"nctId":3302,"briefTitle":3303,"status":529,"phases":3363,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":3364,"interventions":3365},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":2660,"totalTrials":508,"cells":3367},{"EARLY_PHASE1":3368,"PHASE1":3370,"PHASE2":3372,"PHASE3":3378,"PHASE4":3380,"NA":3382},{"trials":3369,"activeCount":101},[],{"trials":3371,"activeCount":101},[],{"trials":3373,"activeCount":101},[3374],{"nctId":2652,"briefTitle":2653,"status":529,"phases":3375,"primaryCompletion":2655,"completion":911,"start":2656,"enrollment":284,"conditions":3376,"interventions":3377},[91],[2658],[2643,2660],{"trials":3379,"activeCount":101},[],{"trials":3381,"activeCount":101},[],{"trials":3383,"activeCount":101},[3384],{"nctId":3385,"briefTitle":3386,"status":795,"phases":3387,"primaryCompletion":910,"completion":911,"start":728,"enrollment":1747,"conditions":3388,"interventions":3391},"NCT03229330","Low-level Light Therapy on Treatment of Venous Ulcers Assesed by Nursing Outcome Classification (NOC)",[94],[3389,3390],"Venous Ulcer","Low-Level Light Therapy",[3392],"Conventional treatment",{"intervention":3394,"totalTrials":508,"cells":3395},"Furosemide",{"EARLY_PHASE1":3396,"PHASE1":3398,"PHASE2":3400,"PHASE3":3402,"PHASE4":3414,"NA":3416},{"trials":3397,"activeCount":101},[],{"trials":3399,"activeCount":101},[],{"trials":3401,"activeCount":101},[],{"trials":3403,"activeCount":101},[3404],{"nctId":3405,"briefTitle":3406,"status":529,"phases":3407,"primaryCompletion":3408,"completion":3409,"start":3410,"enrollment":3411,"conditions":3412,"interventions":3413},"NCT02689180","Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients",[92],"2017-05","2017-07","2015-05",230,[21],[3394],{"trials":3415,"activeCount":101},[],{"trials":3417,"activeCount":101},[3418],{"nctId":3419,"briefTitle":3420,"status":795,"phases":3421,"primaryCompletion":2313,"completion":2313,"start":2138,"enrollment":3422,"conditions":3423,"interventions":3424},"NCT02068937","Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients",[94],206,[21],[3425,3394],"Furosemide and Phone contact",{"intervention":3427,"totalTrials":508,"cells":3428},"fluoxetine",{"EARLY_PHASE1":3429,"PHASE1":3431,"PHASE2":3433,"PHASE3":3435,"PHASE4":3437,"NA":3439},{"trials":3430,"activeCount":101},[],{"trials":3432,"activeCount":101},[],{"trials":3434,"activeCount":101},[],{"trials":3436,"activeCount":101},[],{"trials":3438,"activeCount":101},[],{"trials":3440,"activeCount":101},[3441,3466],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3444,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3447,"interventions":3449},"NCT01896349","Interpersonal Psychotherapy for Treatment Resistant Depression",[94],"2014-11","2013-04",[3448],"Treatment Resistant Depression",[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],"sertraline","paroxetine","Citalopram","escitalopram","fluvoxamine","Venlafaxine","Bupropion","Lithium","tranylcypromine","Imipramine","amitriptyline","Clomipramine","nortriptyline","trazodone","Mirtazapine","sulpiride",{"nctId":3467,"briefTitle":3468,"status":795,"phases":3469,"primaryCompletion":911,"completion":911,"start":2289,"enrollment":3470,"conditions":3471,"interventions":3473},"NCT03072264","Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder",[94],200,[3472],"Generalized Anxiety Disorder",[3474],"Fluoxetine",{"intervention":774,"totalTrials":508,"cells":3476},{"EARLY_PHASE1":3477,"PHASE1":3479,"PHASE2":3481,"PHASE3":3483,"PHASE4":3485,"NA":3491},{"trials":3478,"activeCount":101},[],{"trials":3480,"activeCount":101},[],{"trials":3482,"activeCount":101},[],{"trials":3484,"activeCount":101},[],{"trials":3486,"activeCount":101},[3487],{"nctId":763,"briefTitle":764,"status":529,"phases":3488,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":3489,"interventions":3490},[93],[771],[773,774,775,776],{"trials":3492,"activeCount":101},[3493],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3494,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3495,"interventions":3496},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":537,"totalTrials":97,"cells":3498},{"EARLY_PHASE1":3499,"PHASE1":3501,"PHASE2":3503,"PHASE3":3505,"PHASE4":3507,"NA":3509},{"trials":3500,"activeCount":101},[],{"trials":3502,"activeCount":101},[],{"trials":3504,"activeCount":101},[],{"trials":3506,"activeCount":101},[],{"trials":3508,"activeCount":101},[],{"trials":3510,"activeCount":101},[3511],{"nctId":527,"briefTitle":528,"status":529,"phases":3512,"primaryCompletion":531,"completion":532,"start":533,"enrollment":534,"conditions":3513,"interventions":3514},[94],[29],[460,537],{"intervention":3516,"totalTrials":97,"cells":3517},"single dose of Anti-thymocyte globulin",{"EARLY_PHASE1":3518,"PHASE1":3520,"PHASE2":3522,"PHASE3":3524,"PHASE4":3526,"NA":3528},{"trials":3519,"activeCount":101},[],{"trials":3521,"activeCount":101},[],{"trials":3523,"activeCount":101},[],{"trials":3525,"activeCount":101},[],{"trials":3527,"activeCount":101},[],{"trials":3529,"activeCount":101},[3530],{"nctId":3531,"briefTitle":3532,"status":795,"phases":3533,"primaryCompletion":3534,"completion":3535,"start":3536,"enrollment":3470,"conditions":3537,"interventions":3540},"NCT04835948","Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation",[],"2020-03-31","2021-04-13","2018-10-20",[3538,3539],"Kidney Transplant; Complications","Immunosuppression",[3516],{"intervention":3542,"totalTrials":97,"cells":3543},"Oral hormone therapy",{"EARLY_PHASE1":3544,"PHASE1":3546,"PHASE2":3548,"PHASE3":3550,"PHASE4":3552,"NA":3554},{"trials":3545,"activeCount":101},[],{"trials":3547,"activeCount":101},[],{"trials":3549,"activeCount":101},[],{"trials":3551,"activeCount":101},[],{"trials":3553,"activeCount":101},[],{"trials":3555,"activeCount":101},[3556],{"nctId":3557,"briefTitle":3558,"status":529,"phases":3559,"primaryCompletion":3560,"completion":1018,"start":3561,"enrollment":729,"conditions":3562,"interventions":3565},"NCT04453332","Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters",[94],"2021-06","2015-10-09",[3563,3564],"Menopause","Hormone Replacement Therapy",[3542,3566],"Non-oral hormone therapy",{"intervention":3566,"totalTrials":97,"cells":3568},{"EARLY_PHASE1":3569,"PHASE1":3571,"PHASE2":3573,"PHASE3":3575,"PHASE4":3577,"NA":3579},{"trials":3570,"activeCount":101},[],{"trials":3572,"activeCount":101},[],{"trials":3574,"activeCount":101},[],{"trials":3576,"activeCount":101},[],{"trials":3578,"activeCount":101},[],{"trials":3580,"activeCount":101},[3581],{"nctId":3557,"briefTitle":3558,"status":529,"phases":3582,"primaryCompletion":3560,"completion":1018,"start":3561,"enrollment":729,"conditions":3583,"interventions":3584},[94],[3563,3564],[3542,3566],{"intervention":3586,"totalTrials":97,"cells":3587},"doxycycline plus metronidazole",{"EARLY_PHASE1":3588,"PHASE1":3590,"PHASE2":3592,"PHASE3":3594,"PHASE4":3596,"NA":3598},{"trials":3589,"activeCount":101},[],{"trials":3591,"activeCount":101},[],{"trials":3593,"activeCount":101},[],{"trials":3595,"activeCount":101},[],{"trials":3597,"activeCount":101},[],{"trials":3599,"activeCount":101},[3600],{"nctId":3601,"briefTitle":3602,"status":1181,"phases":3603,"primaryCompletion":3604,"completion":1183,"start":1184,"enrollment":1185,"conditions":3605,"interventions":3607},"NCT00353743","The Use of Antibiotics After Hospital Discharge in Septic Abortion",[94],"2007-11",[3606],"Abortion, Septic",[3586],{"intervention":3609,"totalTrials":97,"cells":3610},"enalapril",{"EARLY_PHASE1":3611,"PHASE1":3613,"PHASE2":3615,"PHASE3":3617,"PHASE4":3619,"NA":3621},{"trials":3612,"activeCount":101},[],{"trials":3614,"activeCount":101},[],{"trials":3616,"activeCount":101},[],{"trials":3618,"activeCount":101},[],{"trials":3620,"activeCount":101},[],{"trials":3622,"activeCount":101},[3623],{"nctId":3624,"briefTitle":3625,"status":795,"phases":3626,"completion":3627,"start":3628,"enrollment":11,"conditions":3629,"interventions":3631},"NCT00484068","Chicken-Diet vs. Enalapril to Reduce Albuminuria",[94],"2006-06","2003-01",[1212,3630],"Diabetic Nephropathy",[3609],{"intervention":3633,"totalTrials":97,"cells":3634},"intravitreous triamcinolone",{"EARLY_PHASE1":3635,"PHASE1":3637,"PHASE2":3639,"PHASE3":3641,"PHASE4":3643,"NA":3645},{"trials":3636,"activeCount":101},[],{"trials":3638,"activeCount":101},[],{"trials":3640,"activeCount":101},[],{"trials":3642,"activeCount":101},[],{"trials":3644,"activeCount":101},[],{"trials":3646,"activeCount":101},[3647],{"nctId":3648,"briefTitle":3649,"status":795,"phases":3650,"primaryCompletion":3651,"completion":3627,"start":3652,"enrollment":3653,"conditions":3654,"interventions":3656},"NCT00668239","Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser",[94],"2006-04","2004-09",14,[3655],"Macular Edema",[3633],{"intervention":3658,"totalTrials":97,"cells":3659},"Tranexamic acid",{"EARLY_PHASE1":3660,"PHASE1":3662,"PHASE2":3664,"PHASE3":3666,"PHASE4":3668,"NA":3670},{"trials":3661,"activeCount":101},[],{"trials":3663,"activeCount":101},[],{"trials":3665,"activeCount":101},[],{"trials":3667,"activeCount":101},[],{"trials":3669,"activeCount":101},[],{"trials":3671,"activeCount":101},[3672],{"nctId":3673,"briefTitle":3674,"status":529,"phases":3675,"primaryCompletion":3676,"completion":3677,"start":3678,"enrollment":3679,"conditions":3680,"interventions":3682},"NCT04753151","The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.",[94],"2022-12-31","2023-07-30","2021-08-11",140,[3681],"Hemorrhage",[3658],{"intervention":3425,"totalTrials":97,"cells":3684},{"EARLY_PHASE1":3685,"PHASE1":3687,"PHASE2":3689,"PHASE3":3691,"PHASE4":3693,"NA":3695},{"trials":3686,"activeCount":101},[],{"trials":3688,"activeCount":101},[],{"trials":3690,"activeCount":101},[],{"trials":3692,"activeCount":101},[],{"trials":3694,"activeCount":101},[],{"trials":3696,"activeCount":101},[3697],{"nctId":3419,"briefTitle":3420,"status":795,"phases":3698,"primaryCompletion":2313,"completion":2313,"start":2138,"enrollment":3422,"conditions":3699,"interventions":3700},[94],[21],[3425,3394],{"intervention":3702,"totalTrials":97,"cells":3703},"Treatment as Usual",{"EARLY_PHASE1":3704,"PHASE1":3706,"PHASE2":3708,"PHASE3":3710,"PHASE4":3712,"NA":3714},{"trials":3705,"activeCount":101},[],{"trials":3707,"activeCount":101},[],{"trials":3709,"activeCount":101},[],{"trials":3711,"activeCount":101},[],{"trials":3713,"activeCount":101},[],{"trials":3715,"activeCount":101},[3716],{"nctId":3717,"briefTitle":3718,"status":795,"phases":3719,"primaryCompletion":3720,"completion":3721,"start":3722,"enrollment":729,"conditions":3723,"interventions":3724},"NCT05375851","Digital Interventions As an Add-on Tool in Generalized Anxiety Disorder Treatment",[94],"2023-08-23","2024-02-28","2022-05-01",[3472],[3702],{"intervention":3726,"totalTrials":97,"cells":3727},"Intravenous Insulin",{"EARLY_PHASE1":3728,"PHASE1":3730,"PHASE2":3732,"PHASE3":3734,"PHASE4":3736,"NA":3738},{"trials":3729,"activeCount":101},[],{"trials":3731,"activeCount":101},[],{"trials":3733,"activeCount":101},[],{"trials":3735,"activeCount":101},[],{"trials":3737,"activeCount":101},[],{"trials":3739,"activeCount":101},[3740],{"nctId":3741,"briefTitle":3742,"status":1181,"phases":3743,"primaryCompletion":3744,"completion":2186,"start":2095,"enrollment":3745,"conditions":3746,"interventions":3748},"NCT00967642","Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)",[94],"2008-07",70,[1211,3747],"Percutaneous Coronary Intervention",[3726],{"intervention":3750,"totalTrials":97,"cells":3751},"randomization between the two GnRH analogues",{"EARLY_PHASE1":3752,"PHASE1":3754,"PHASE2":3756,"PHASE3":3758,"PHASE4":3760,"NA":3762},{"trials":3753,"activeCount":101},[],{"trials":3755,"activeCount":101},[],{"trials":3757,"activeCount":101},[],{"trials":3759,"activeCount":101},[],{"trials":3761,"activeCount":101},[],{"trials":3763,"activeCount":101},[3764],{"nctId":3765,"briefTitle":3766,"status":529,"phases":3767,"primaryCompletion":3768,"start":1720,"enrollment":11,"conditions":3769,"interventions":3771},"NCT01946022","Evaluation of Granulosa Cells Function After IVF Protocols",[94],"2014-10",[1047,3770],"In Vitro Fertilization Protocols",[3750],{"intervention":3773,"totalTrials":97,"cells":3774},"ECT + Ketamine",{"EARLY_PHASE1":3775,"PHASE1":3777,"PHASE2":3779,"PHASE3":3781,"PHASE4":3783,"NA":3785},{"trials":3776,"activeCount":101},[],{"trials":3778,"activeCount":101},[],{"trials":3780,"activeCount":101},[],{"trials":3782,"activeCount":101},[],{"trials":3784,"activeCount":101},[],{"trials":3786,"activeCount":101},[3787],{"nctId":3788,"briefTitle":3789,"status":2679,"phases":3790,"primaryCompletion":3000,"completion":3000,"start":1044,"enrollment":101,"conditions":3791,"interventions":3792},"NCT02012335","Ketamine Use in Electroconvulsive Therapy",[94],[3003],[3773],{"intervention":3450,"totalTrials":97,"cells":3794},{"EARLY_PHASE1":3795,"PHASE1":3797,"PHASE2":3799,"PHASE3":3801,"PHASE4":3803,"NA":3805},{"trials":3796,"activeCount":101},[],{"trials":3798,"activeCount":101},[],{"trials":3800,"activeCount":101},[],{"trials":3802,"activeCount":101},[],{"trials":3804,"activeCount":101},[],{"trials":3806,"activeCount":101},[3807],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3808,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3809,"interventions":3810},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3451,"totalTrials":97,"cells":3812},{"EARLY_PHASE1":3813,"PHASE1":3815,"PHASE2":3817,"PHASE3":3819,"PHASE4":3821,"NA":3823},{"trials":3814,"activeCount":101},[],{"trials":3816,"activeCount":101},[],{"trials":3818,"activeCount":101},[],{"trials":3820,"activeCount":101},[],{"trials":3822,"activeCount":101},[],{"trials":3824,"activeCount":101},[3825],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3826,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3827,"interventions":3828},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3452,"totalTrials":97,"cells":3830},{"EARLY_PHASE1":3831,"PHASE1":3833,"PHASE2":3835,"PHASE3":3837,"PHASE4":3839,"NA":3841},{"trials":3832,"activeCount":101},[],{"trials":3834,"activeCount":101},[],{"trials":3836,"activeCount":101},[],{"trials":3838,"activeCount":101},[],{"trials":3840,"activeCount":101},[],{"trials":3842,"activeCount":101},[3843],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3844,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3845,"interventions":3846},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3453,"totalTrials":97,"cells":3848},{"EARLY_PHASE1":3849,"PHASE1":3851,"PHASE2":3853,"PHASE3":3855,"PHASE4":3857,"NA":3859},{"trials":3850,"activeCount":101},[],{"trials":3852,"activeCount":101},[],{"trials":3854,"activeCount":101},[],{"trials":3856,"activeCount":101},[],{"trials":3858,"activeCount":101},[],{"trials":3860,"activeCount":101},[3861],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3862,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3863,"interventions":3864},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3454,"totalTrials":97,"cells":3866},{"EARLY_PHASE1":3867,"PHASE1":3869,"PHASE2":3871,"PHASE3":3873,"PHASE4":3875,"NA":3877},{"trials":3868,"activeCount":101},[],{"trials":3870,"activeCount":101},[],{"trials":3872,"activeCount":101},[],{"trials":3874,"activeCount":101},[],{"trials":3876,"activeCount":101},[],{"trials":3878,"activeCount":101},[3879],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3880,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3881,"interventions":3882},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3455,"totalTrials":97,"cells":3884},{"EARLY_PHASE1":3885,"PHASE1":3887,"PHASE2":3889,"PHASE3":3891,"PHASE4":3893,"NA":3895},{"trials":3886,"activeCount":101},[],{"trials":3888,"activeCount":101},[],{"trials":3890,"activeCount":101},[],{"trials":3892,"activeCount":101},[],{"trials":3894,"activeCount":101},[],{"trials":3896,"activeCount":101},[3897],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3898,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3899,"interventions":3900},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":687,"totalTrials":97,"cells":3902},{"EARLY_PHASE1":3903,"PHASE1":3905,"PHASE2":3907,"PHASE3":3909,"PHASE4":3911,"NA":3913},{"trials":3904,"activeCount":101},[],{"trials":3906,"activeCount":101},[],{"trials":3908,"activeCount":101},[],{"trials":3910,"activeCount":101},[],{"trials":3912,"activeCount":101},[],{"trials":3914,"activeCount":101},[3915],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3916,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3917,"interventions":3918},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3456,"totalTrials":97,"cells":3920},{"EARLY_PHASE1":3921,"PHASE1":3923,"PHASE2":3925,"PHASE3":3927,"PHASE4":3929,"NA":3931},{"trials":3922,"activeCount":101},[],{"trials":3924,"activeCount":101},[],{"trials":3926,"activeCount":101},[],{"trials":3928,"activeCount":101},[],{"trials":3930,"activeCount":101},[],{"trials":3932,"activeCount":101},[3933],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3934,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3935,"interventions":3936},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3457,"totalTrials":97,"cells":3938},{"EARLY_PHASE1":3939,"PHASE1":3941,"PHASE2":3943,"PHASE3":3945,"PHASE4":3947,"NA":3949},{"trials":3940,"activeCount":101},[],{"trials":3942,"activeCount":101},[],{"trials":3944,"activeCount":101},[],{"trials":3946,"activeCount":101},[],{"trials":3948,"activeCount":101},[],{"trials":3950,"activeCount":101},[3951],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3952,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3953,"interventions":3954},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3458,"totalTrials":97,"cells":3956},{"EARLY_PHASE1":3957,"PHASE1":3959,"PHASE2":3961,"PHASE3":3963,"PHASE4":3965,"NA":3967},{"trials":3958,"activeCount":101},[],{"trials":3960,"activeCount":101},[],{"trials":3962,"activeCount":101},[],{"trials":3964,"activeCount":101},[],{"trials":3966,"activeCount":101},[],{"trials":3968,"activeCount":101},[3969],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3970,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3971,"interventions":3972},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3459,"totalTrials":97,"cells":3974},{"EARLY_PHASE1":3975,"PHASE1":3977,"PHASE2":3979,"PHASE3":3981,"PHASE4":3983,"NA":3985},{"trials":3976,"activeCount":101},[],{"trials":3978,"activeCount":101},[],{"trials":3980,"activeCount":101},[],{"trials":3982,"activeCount":101},[],{"trials":3984,"activeCount":101},[],{"trials":3986,"activeCount":101},[3987],{"nctId":3442,"briefTitle":3443,"status":529,"phases":3988,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":3989,"interventions":3990},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3460,"totalTrials":97,"cells":3992},{"EARLY_PHASE1":3993,"PHASE1":3995,"PHASE2":3997,"PHASE3":3999,"PHASE4":4001,"NA":4003},{"trials":3994,"activeCount":101},[],{"trials":3996,"activeCount":101},[],{"trials":3998,"activeCount":101},[],{"trials":4000,"activeCount":101},[],{"trials":4002,"activeCount":101},[],{"trials":4004,"activeCount":101},[4005],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4006,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4007,"interventions":4008},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3461,"totalTrials":97,"cells":4010},{"EARLY_PHASE1":4011,"PHASE1":4013,"PHASE2":4015,"PHASE3":4017,"PHASE4":4019,"NA":4021},{"trials":4012,"activeCount":101},[],{"trials":4014,"activeCount":101},[],{"trials":4016,"activeCount":101},[],{"trials":4018,"activeCount":101},[],{"trials":4020,"activeCount":101},[],{"trials":4022,"activeCount":101},[4023],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4024,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4025,"interventions":4026},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3462,"totalTrials":97,"cells":4028},{"EARLY_PHASE1":4029,"PHASE1":4031,"PHASE2":4033,"PHASE3":4035,"PHASE4":4037,"NA":4039},{"trials":4030,"activeCount":101},[],{"trials":4032,"activeCount":101},[],{"trials":4034,"activeCount":101},[],{"trials":4036,"activeCount":101},[],{"trials":4038,"activeCount":101},[],{"trials":4040,"activeCount":101},[4041],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4042,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4043,"interventions":4044},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3463,"totalTrials":97,"cells":4046},{"EARLY_PHASE1":4047,"PHASE1":4049,"PHASE2":4051,"PHASE3":4053,"PHASE4":4055,"NA":4057},{"trials":4048,"activeCount":101},[],{"trials":4050,"activeCount":101},[],{"trials":4052,"activeCount":101},[],{"trials":4054,"activeCount":101},[],{"trials":4056,"activeCount":101},[],{"trials":4058,"activeCount":101},[4059],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4060,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4061,"interventions":4062},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3464,"totalTrials":97,"cells":4064},{"EARLY_PHASE1":4065,"PHASE1":4067,"PHASE2":4069,"PHASE3":4071,"PHASE4":4073,"NA":4075},{"trials":4066,"activeCount":101},[],{"trials":4068,"activeCount":101},[],{"trials":4070,"activeCount":101},[],{"trials":4072,"activeCount":101},[],{"trials":4074,"activeCount":101},[],{"trials":4076,"activeCount":101},[4077],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4078,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4079,"interventions":4080},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":3465,"totalTrials":97,"cells":4082},{"EARLY_PHASE1":4083,"PHASE1":4085,"PHASE2":4087,"PHASE3":4089,"PHASE4":4091,"NA":4093},{"trials":4084,"activeCount":101},[],{"trials":4086,"activeCount":101},[],{"trials":4088,"activeCount":101},[],{"trials":4090,"activeCount":101},[],{"trials":4092,"activeCount":101},[],{"trials":4094,"activeCount":101},[4095],{"nctId":3442,"briefTitle":3443,"status":529,"phases":4096,"primaryCompletion":2607,"completion":3445,"start":3446,"enrollment":1884,"conditions":4097,"interventions":4098},[94],[3448],[3427,3450,3451,3452,3453,3454,3455,687,3456,3457,774,3458,3459,3460,3461,3462,3463,3464,3465],{"intervention":4100,"totalTrials":97,"cells":4101},"Colecalciferol (Vitamin D3) 300.000 UI",{"EARLY_PHASE1":4102,"PHASE1":4104,"PHASE2":4106,"PHASE3":4108,"PHASE4":4110,"NA":4112},{"trials":4103,"activeCount":101},[],{"trials":4105,"activeCount":101},[],{"trials":4107,"activeCount":101},[],{"trials":4109,"activeCount":101},[],{"trials":4111,"activeCount":101},[],{"trials":4113,"activeCount":101},[4114],{"nctId":4115,"briefTitle":4116,"status":529,"phases":4117,"primaryCompletion":1570,"completion":1570,"start":2030,"enrollment":4118,"conditions":4119,"interventions":4122},"NCT01075022","Effect of a Single Colecalciferol Dose on Insulin Resistance",[94],136,[4120,4121],"Insulin Resistance","Glucose Intolerance",[4100],{"intervention":4124,"totalTrials":97,"cells":4125},"Psychostimulant",{"EARLY_PHASE1":4126,"PHASE1":4128,"PHASE2":4130,"PHASE3":4132,"PHASE4":4134,"NA":4136},{"trials":4127,"activeCount":101},[],{"trials":4129,"activeCount":101},[],{"trials":4131,"activeCount":101},[],{"trials":4133,"activeCount":101},[],{"trials":4135,"activeCount":101},[],{"trials":4137,"activeCount":101},[4138],{"nctId":4139,"briefTitle":4140,"status":795,"phases":4141,"primaryCompletion":4142,"completion":4143,"start":4144,"enrollment":4145,"conditions":4146,"interventions":4148},"NCT05551689","FOCUS ADHD Mobile Health App for Adult ADHD Patients",[94],"2022-09-30","2023-03-30","2021-05-21",73,[4147],"ADHD",[4124],{"intervention":4150,"totalTrials":97,"cells":4151},"Corifollitropin Alfa",{"EARLY_PHASE1":4152,"PHASE1":4154,"PHASE2":4156,"PHASE3":4158,"PHASE4":4160,"NA":4162},{"trials":4153,"activeCount":101},[],{"trials":4155,"activeCount":101},[],{"trials":4157,"activeCount":101},[],{"trials":4159,"activeCount":101},[],{"trials":4161,"activeCount":101},[],{"trials":4163,"activeCount":101},[4164],{"nctId":4165,"briefTitle":4166,"status":795,"phases":4167,"primaryCompletion":4168,"completion":4168,"start":4169,"enrollment":4170,"conditions":4171,"interventions":4173},"NCT04416607","Corifollitropin Alpha and Ovarian Response",[94],"2019-01-31","2018-06-15",300,[4172],"Infertility, Female",[4150,4174],"Menotropins",{"intervention":4174,"totalTrials":97,"cells":4176},{"EARLY_PHASE1":4177,"PHASE1":4179,"PHASE2":4181,"PHASE3":4183,"PHASE4":4185,"NA":4187},{"trials":4178,"activeCount":101},[],{"trials":4180,"activeCount":101},[],{"trials":4182,"activeCount":101},[],{"trials":4184,"activeCount":101},[],{"trials":4186,"activeCount":101},[],{"trials":4188,"activeCount":101},[4189],{"nctId":4165,"briefTitle":4166,"status":795,"phases":4190,"primaryCompletion":4168,"completion":4168,"start":4169,"enrollment":4170,"conditions":4191,"interventions":4192},[94],[4172],[4150,4174],{"intervention":4194,"totalTrials":97,"cells":4195},"Pyridostigmine",{"EARLY_PHASE1":4196,"PHASE1":4198,"PHASE2":4200,"PHASE3":4202,"PHASE4":4204,"NA":4206},{"trials":4197,"activeCount":101},[],{"trials":4199,"activeCount":101},[],{"trials":4201,"activeCount":101},[],{"trials":4203,"activeCount":101},[],{"trials":4205,"activeCount":101},[],{"trials":4207,"activeCount":101},[4208],{"nctId":4209,"briefTitle":4210,"status":795,"phases":4211,"primaryCompletion":2029,"completion":1926,"start":4212,"enrollment":1747,"conditions":4213,"interventions":4215},"NCT00953914","Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients",[94],"2005-03",[4214],"Diabetes Complications",[4194],{"intervention":4217,"totalTrials":97,"cells":4218},"Esmolol, Sodium Nitroprussiate",{"EARLY_PHASE1":4219,"PHASE1":4221,"PHASE2":4223,"PHASE3":4225,"PHASE4":4227,"NA":4229},{"trials":4220,"activeCount":101},[],{"trials":4222,"activeCount":101},[],{"trials":4224,"activeCount":101},[],{"trials":4226,"activeCount":101},[],{"trials":4228,"activeCount":101},[],{"trials":4230,"activeCount":101},[4231],{"nctId":4232,"briefTitle":4233,"status":529,"phases":4234,"primaryCompletion":1112,"completion":1112,"start":1308,"enrollment":4235,"conditions":4236,"interventions":4238},"NCT00848770","Manipulation of Arterial Pressure in Acute Ischemic Stroke",[94],240,[4237],"Stroke, Acute",[4217,4239,4240],"Esmolol, NPS or NOR","manipulation of SAP",{"intervention":4239,"totalTrials":97,"cells":4242},{"EARLY_PHASE1":4243,"PHASE1":4245,"PHASE2":4247,"PHASE3":4249,"PHASE4":4251,"NA":4253},{"trials":4244,"activeCount":101},[],{"trials":4246,"activeCount":101},[],{"trials":4248,"activeCount":101},[],{"trials":4250,"activeCount":101},[],{"trials":4252,"activeCount":101},[],{"trials":4254,"activeCount":101},[4255],{"nctId":4232,"briefTitle":4233,"status":529,"phases":4256,"primaryCompletion":1112,"completion":1112,"start":1308,"enrollment":4235,"conditions":4257,"interventions":4258},[94],[4237],[4217,4239,4240],{"intervention":4240,"totalTrials":97,"cells":4260},{"EARLY_PHASE1":4261,"PHASE1":4263,"PHASE2":4265,"PHASE3":4267,"PHASE4":4269,"NA":4271},{"trials":4262,"activeCount":101},[],{"trials":4264,"activeCount":101},[],{"trials":4266,"activeCount":101},[],{"trials":4268,"activeCount":101},[],{"trials":4270,"activeCount":101},[],{"trials":4272,"activeCount":101},[4273],{"nctId":4232,"briefTitle":4233,"status":529,"phases":4274,"primaryCompletion":1112,"completion":1112,"start":1308,"enrollment":4235,"conditions":4275,"interventions":4276},[94],[4237],[4217,4239,4240],{"intervention":4278,"totalTrials":97,"cells":4279},"Itraconazole 200 mg",{"EARLY_PHASE1":4280,"PHASE1":4282,"PHASE2":4284,"PHASE3":4286,"PHASE4":4288,"NA":4290},{"trials":4281,"activeCount":101},[],{"trials":4283,"activeCount":101},[],{"trials":4285,"activeCount":101},[],{"trials":4287,"activeCount":101},[],{"trials":4289,"activeCount":101},[],{"trials":4291,"activeCount":101},[4292],{"nctId":4293,"briefTitle":4294,"status":529,"phases":4295,"primaryCompletion":4296,"completion":4297,"start":4298,"enrollment":11,"conditions":4299,"interventions":4302},"NCT03972748","Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.",[94],"2020-12-01","2021-06-01","2018-01-05",[4300,4301],"Basal Cell Carcinoma","Hedgehog Pathway",[4278],{"intervention":3312,"totalTrials":97,"cells":4304},{"EARLY_PHASE1":4305,"PHASE1":4307,"PHASE2":4309,"PHASE3":4311,"PHASE4":4313,"NA":4315},{"trials":4306,"activeCount":101},[],{"trials":4308,"activeCount":101},[],{"trials":4310,"activeCount":101},[],{"trials":4312,"activeCount":101},[],{"trials":4314,"activeCount":101},[],{"trials":4316,"activeCount":101},[4317],{"nctId":3302,"briefTitle":3303,"status":529,"phases":4318,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":4319,"interventions":4320},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":3313,"totalTrials":97,"cells":4322},{"EARLY_PHASE1":4323,"PHASE1":4325,"PHASE2":4327,"PHASE3":4329,"PHASE4":4331,"NA":4333},{"trials":4324,"activeCount":101},[],{"trials":4326,"activeCount":101},[],{"trials":4328,"activeCount":101},[],{"trials":4330,"activeCount":101},[],{"trials":4332,"activeCount":101},[],{"trials":4334,"activeCount":101},[4335],{"nctId":3302,"briefTitle":3303,"status":529,"phases":4336,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":4337,"interventions":4338},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":3314,"totalTrials":97,"cells":4340},{"EARLY_PHASE1":4341,"PHASE1":4343,"PHASE2":4345,"PHASE3":4347,"PHASE4":4349,"NA":4351},{"trials":4342,"activeCount":101},[],{"trials":4344,"activeCount":101},[],{"trials":4346,"activeCount":101},[],{"trials":4348,"activeCount":101},[],{"trials":4350,"activeCount":101},[],{"trials":4352,"activeCount":101},[4353],{"nctId":3302,"briefTitle":3303,"status":529,"phases":4354,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":4355,"interventions":4356},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":3315,"totalTrials":97,"cells":4358},{"EARLY_PHASE1":4359,"PHASE1":4361,"PHASE2":4363,"PHASE3":4365,"PHASE4":4367,"NA":4369},{"trials":4360,"activeCount":101},[],{"trials":4362,"activeCount":101},[],{"trials":4364,"activeCount":101},[],{"trials":4366,"activeCount":101},[],{"trials":4368,"activeCount":101},[],{"trials":4370,"activeCount":101},[4371],{"nctId":3302,"briefTitle":3303,"status":529,"phases":4372,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":4373,"interventions":4374},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":3316,"totalTrials":97,"cells":4376},{"EARLY_PHASE1":4377,"PHASE1":4379,"PHASE2":4381,"PHASE3":4383,"PHASE4":4385,"NA":4387},{"trials":4378,"activeCount":101},[],{"trials":4380,"activeCount":101},[],{"trials":4382,"activeCount":101},[],{"trials":4384,"activeCount":101},[],{"trials":4386,"activeCount":101},[],{"trials":4388,"activeCount":101},[4389],{"nctId":3302,"briefTitle":3303,"status":529,"phases":4390,"primaryCompletion":3305,"completion":3306,"start":3307,"enrollment":3308,"conditions":4391,"interventions":4392},[],[1211,3310],[1526,3312,3313,3314,3315,3316,1587],{"intervention":4394,"totalTrials":97,"cells":4395},"Velpatasvir\u002FSofosbuvir",{"EARLY_PHASE1":4396,"PHASE1":4398,"PHASE2":4400,"PHASE3":4402,"PHASE4":4404,"NA":4406},{"trials":4397,"activeCount":101},[],{"trials":4399,"activeCount":101},[],{"trials":4401,"activeCount":101},[],{"trials":4403,"activeCount":101},[],{"trials":4405,"activeCount":101},[],{"trials":4407,"activeCount":101},[4408],{"nctId":4409,"briefTitle":4410,"status":529,"phases":4411,"primaryCompletion":4412,"completion":4413,"start":4414,"enrollment":4415,"conditions":4416,"interventions":4418},"NCT04039698","Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil",[94],"2020-12-16","2021-11","2019-08-23",144,[4417],"Chronic Hepatitis C",[4394]]